<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T02:06:53Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:9170475" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:9170475</identifier>
        <datestamp>2022-06-08</datestamp>
        <setSpec>ajcn</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" dtd-version="1.3" xml:lang="en" article-type="research-article">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">Am J Clin Nutr</journal-id>
              <journal-id journal-id-type="iso-abbrev">Am J Clin Nutr</journal-id>
              <journal-id journal-id-type="publisher-id">ajcn</journal-id>
              <journal-title-group>
                <journal-title>The American Journal of Clinical Nutrition</journal-title>
              </journal-title-group>
              <issn pub-type="ppub">0002-9165</issn>
              <issn pub-type="epub">1938-3207</issn>
              <publisher>
                <publisher-name>Oxford University Press</publisher-name>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC9170475</article-id>
              <article-id pub-id-type="pmcid">PMC9170475</article-id>
              <article-id pub-id-type="pmc-uid">9170475</article-id>
              <article-id pub-id-type="pmid">35294969</article-id>
              <article-id pub-id-type="pmid">35294969</article-id>
              <article-id pub-id-type="doi">10.1093/ajcn/nqac056</article-id>
              <article-id pub-id-type="publisher-id">nqac056</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Original Research Communications</subject>
                  <subj-group subj-group-type="category-toc-heading">
                    <subject>Dietary Supplements</subject>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="category-taxonomy-collection">
                  <subject>AcademicSubjects/MED00060</subject>
                  <subject>AcademicSubjects/MED00160</subject>
                </subj-group>
                <subj-group subj-group-type="category-oup-series">
                  <subject>Editor's Choice</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Multivitamins in the prevention of cancer and cardiovascular disease: the COcoa Supplement and Multivitamin Outcomes Study (COSMOS) randomized clinical trial</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author" corresp="yes">
                  <name>
                    <surname>Sesso</surname>
                    <given-names>Howard D</given-names>
                  </name>
                  <!--hsesso@bwh.harvard.edu-->
                  <aff><institution>Division of Preventive Medicine, Brigham and Women's Hospital and Harvard Medical School</institution>, Boston, MA, <country country="US">USA</country></aff>
                  <aff><institution>Department of Epidemiology, Harvard T.H. Chan School of Public Health</institution>, Boston, MA, <country country="US">USA</country></aff>
                  <xref rid="cor1" ref-type="corresp"/>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Rist</surname>
                    <given-names>Pamela M</given-names>
                  </name>
                  <aff><institution>Division of Preventive Medicine, Brigham and Women's Hospital and Harvard Medical School</institution>, Boston, MA, <country country="US">USA</country></aff>
                  <aff><institution>Department of Epidemiology, Harvard T.H. Chan School of Public Health</institution>, Boston, MA, <country country="US">USA</country></aff>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Aragaki</surname>
                    <given-names>Aaron K</given-names>
                  </name>
                  <aff><institution>Division of Public Health Sciences, Fred Hutchinson Cancer Research Center</institution>, Seattle, WA, <country country="US">USA</country></aff>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Rautiainen</surname>
                    <given-names>Susanne</given-names>
                  </name>
                  <aff><institution>Division of Preventive Medicine, Brigham and Women's Hospital and Harvard Medical School</institution>, Boston, MA, <country country="US">USA</country></aff>
                  <aff><institution>Department of Global Public Health, Karolinska Institutet</institution>, Stockholm, <country country="SE">Sweden</country></aff>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Johnson</surname>
                    <given-names>Lisa G</given-names>
                  </name>
                  <aff><institution>Division of Public Health Sciences, Fred Hutchinson Cancer Research Center</institution>, Seattle, WA, <country country="US">USA</country></aff>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Friedenberg</surname>
                    <given-names>Georgina</given-names>
                  </name>
                  <aff><institution>Division of Preventive Medicine, Brigham and Women's Hospital and Harvard Medical School</institution>, Boston, MA, <country country="US">USA</country></aff>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Copeland</surname>
                    <given-names>Trisha</given-names>
                  </name>
                  <aff><institution>Division of Preventive Medicine, Brigham and Women's Hospital and Harvard Medical School</institution>, Boston, MA, <country country="US">USA</country></aff>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Clar</surname>
                    <given-names>Allison</given-names>
                  </name>
                  <aff><institution>Division of Preventive Medicine, Brigham and Women's Hospital and Harvard Medical School</institution>, Boston, MA, <country country="US">USA</country></aff>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-6283-0980</contrib-id>
                  <name>
                    <surname>Mora</surname>
                    <given-names>Samia</given-names>
                  </name>
                  <aff><institution>Division of Preventive Medicine, Brigham and Women's Hospital and Harvard Medical School</institution>, Boston, MA, <country country="US">USA</country></aff>
                  <aff><institution>Division of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School</institution>, Boston, MA, <country country="US">USA</country></aff>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Moorthy</surname>
                    <given-names>M Vinayaga</given-names>
                  </name>
                  <aff><institution>Division of Preventive Medicine, Brigham and Women's Hospital and Harvard Medical School</institution>, Boston, MA, <country country="US">USA</country></aff>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Sarkissian</surname>
                    <given-names>Ara</given-names>
                  </name>
                  <aff><institution>Division of Preventive Medicine, Brigham and Women's Hospital and Harvard Medical School</institution>, Boston, MA, <country country="US">USA</country></aff>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-3096-9595</contrib-id>
                  <name>
                    <surname>Wactawski-Wende</surname>
                    <given-names>Jean</given-names>
                  </name>
                  <aff><institution>Department of Epidemiology and Environmental Health, School of Public Health and Health Professions, State University of New York at Buffalo</institution>, Buffalo, NY, <country country="US">USA</country></aff>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Tinker</surname>
                    <given-names>Lesley F</given-names>
                  </name>
                  <aff><institution>Division of Public Health Sciences, Fred Hutchinson Cancer Research Center</institution>, Seattle, WA, <country country="US">USA</country></aff>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Carrick</surname>
                    <given-names>William R</given-names>
                  </name>
                  <aff><institution>Division of Public Health Sciences, Fred Hutchinson Cancer Research Center</institution>, Seattle, WA, <country country="US">USA</country></aff>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-5087-7837</contrib-id>
                  <name>
                    <surname>Anderson</surname>
                    <given-names>Garnet L</given-names>
                  </name>
                  <aff><institution>Division of Public Health Sciences, Fred Hutchinson Cancer Research Center</institution>, Seattle, WA, <country country="US">USA</country></aff>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-9426-7595</contrib-id>
                  <name>
                    <surname>Manson</surname>
                    <given-names>JoAnn E</given-names>
                  </name>
                  <aff><institution>Division of Preventive Medicine, Brigham and Women's Hospital and Harvard Medical School</institution>, Boston, MA, <country country="US">USA</country></aff>
                  <aff><institution>Department of Epidemiology, Harvard T.H. Chan School of Public Health</institution>, Boston, MA, <country country="US">USA</country></aff>
                </contrib>
                <contrib contrib-type="author">
                  <collab>COSMOS Research Group
<contrib-group><contrib contrib-type="author"><name><surname>Manson</surname><given-names>JoAnn E</given-names></name></contrib><contrib contrib-type="author"><name><surname>Sesso</surname><given-names>Howard D</given-names></name></contrib><contrib contrib-type="author"><name><surname>Rist</surname><given-names>Pamela M</given-names></name></contrib><contrib contrib-type="author"><name><surname>Lagerstrom</surname><given-names>Susanne Rautiainen</given-names></name></contrib><contrib contrib-type="author"><name><surname>Bassuk</surname><given-names>Shari S</given-names></name></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Lu</given-names></name></contrib><contrib contrib-type="author"><name><surname>Hazra</surname><given-names>Aditi</given-names></name></contrib><contrib contrib-type="author"><name><surname>Gibson</surname><given-names>Heike</given-names></name></contrib><contrib contrib-type="author"><name><surname>LeBoff</surname><given-names>Meryl S</given-names></name></contrib><contrib contrib-type="author"><name><surname>Mora</surname><given-names>Samia</given-names></name></contrib><contrib contrib-type="author"><name><surname>Okereke</surname><given-names>Olivia I</given-names></name></contrib><contrib contrib-type="author"><name><surname>Tobias</surname><given-names>Deirdre K</given-names></name></contrib><contrib contrib-type="author"><name><surname>Cook</surname><given-names>Nancy R</given-names></name></contrib><contrib contrib-type="author"><name><surname>Chandler</surname><given-names>Paulette D</given-names></name></contrib><contrib contrib-type="author"><name><surname>Christen</surname><given-names>William</given-names></name></contrib><contrib contrib-type="author"><name><surname>Friedenberg</surname><given-names>Georgina</given-names></name></contrib><contrib contrib-type="author"><name><surname>Copeland</surname><given-names>Trisha</given-names></name></contrib><contrib contrib-type="author"><name><surname>Hanna</surname><given-names>Jasmah</given-names></name></contrib><contrib contrib-type="author"><name><surname>Clar</surname><given-names>Allison</given-names></name></contrib><contrib contrib-type="author"><name><surname>D'Agostino</surname><given-names>Denise</given-names></name></contrib><contrib contrib-type="author"><name><surname>Vinayagamoorthy</surname><given-names>Manickavasagar</given-names></name></contrib><contrib contrib-type="author"><name><surname>Gibson</surname><given-names>Heike</given-names></name></contrib><contrib contrib-type="author"><name><surname>Kim</surname><given-names>Eunjung</given-names></name></contrib><contrib contrib-type="author"><name><surname>Van Denburgh</surname><given-names>Martin</given-names></name></contrib><contrib contrib-type="author"><name><surname>Kotler</surname><given-names>Gregory</given-names></name></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Chunying</given-names></name></contrib><contrib contrib-type="author"><name><surname>Bubes</surname><given-names>Vadim</given-names></name></contrib><contrib contrib-type="author"><name><surname>Sarkissian</surname><given-names>Ara</given-names></name></contrib><contrib contrib-type="author"><name><surname>Smith</surname><given-names>Doug</given-names></name></contrib><contrib contrib-type="author"><name><surname>Pereira</surname><given-names>Eduardo C</given-names></name></contrib><contrib contrib-type="author"><name><surname>Okeke</surname><given-names>Melvyn</given-names></name></contrib><contrib contrib-type="author"><name><surname>Roche</surname><given-names>Elise</given-names></name></contrib><contrib contrib-type="author"><name><surname>Bates</surname><given-names>David</given-names></name></contrib><contrib contrib-type="author"><name><surname>Ridge</surname><given-names>Claire</given-names></name></contrib><contrib contrib-type="author"><name><surname>Phillips</surname><given-names>Alexandra</given-names></name></contrib><contrib contrib-type="author"><name><surname>Salvo</surname><given-names>Brielle</given-names></name></contrib><contrib contrib-type="author"><name><surname>Wilson</surname><given-names>Annalee</given-names></name></contrib><contrib contrib-type="author"><name><surname>Hall</surname><given-names>Leah</given-names></name></contrib><contrib contrib-type="author"><name><surname>Baez</surname><given-names>Jimaldy</given-names></name></contrib><contrib contrib-type="author"><name><surname>Sim</surname><given-names>Young-Hwan</given-names></name></contrib><contrib contrib-type="author"><name><surname>Cardoso</surname><given-names>Hayara</given-names></name></contrib><contrib contrib-type="author"><name><surname>Senor</surname><given-names>Gabriel</given-names></name></contrib><contrib contrib-type="author"><name><surname>Rudnicki</surname><given-names>Connor</given-names></name></contrib><contrib contrib-type="author"><name><surname>Huynh</surname><given-names>Hanh</given-names></name></contrib><contrib contrib-type="author"><name><surname>Nguyen</surname><given-names>Viviane</given-names></name></contrib><contrib contrib-type="author"><name><surname>Terrell</surname><given-names>Nicholas</given-names></name></contrib><contrib contrib-type="author"><name><surname>Holman</surname><given-names>Beth A</given-names></name></contrib><contrib contrib-type="author"><name><surname>Walter</surname><given-names>Joseph</given-names></name></contrib><contrib contrib-type="author"><name><surname>Johnson</surname><given-names>Lisa Fields</given-names></name></contrib><contrib contrib-type="author"><name><surname>Casarella</surname><given-names>Amy</given-names></name></contrib><contrib contrib-type="author"><name><surname>O'Connell</surname><given-names>Julia</given-names></name></contrib><contrib contrib-type="author"><name><surname>Christen</surname><given-names>William</given-names></name></contrib><contrib contrib-type="author"><name><surname>Lagerstrom</surname><given-names>Susanne Rautiainen</given-names></name></contrib><contrib contrib-type="author"><name><surname>Djoussé</surname><given-names>Luc</given-names></name></contrib><contrib contrib-type="author"><name><surname>Chandler</surname><given-names>Paulette D</given-names></name></contrib><contrib contrib-type="author"><name><surname>Hazra</surname><given-names>Aditi</given-names></name></contrib><contrib contrib-type="author"><name><surname>Tobias</surname><given-names>Deidre K</given-names></name></contrib><contrib contrib-type="author"><name><surname>Farukhi</surname><given-names>Zareen M</given-names></name></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Lu</given-names></name></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Xuehong</given-names></name></contrib><contrib contrib-type="author"><name><surname>Breen</surname><given-names>Kenneth</given-names></name></contrib><contrib contrib-type="author"><name><surname>Menjin Jr</surname><given-names>George V</given-names></name></contrib><contrib contrib-type="author"><name><surname>Rodriguez</surname><given-names>Rolando</given-names></name></contrib><contrib contrib-type="author"><name><surname>Curry</surname><given-names>Shamikhah</given-names></name></contrib><contrib contrib-type="author"><name><surname>Mora</surname><given-names>Samia</given-names></name></contrib><contrib contrib-type="author"><name><surname>Arsenault</surname><given-names>Leah</given-names></name></contrib><contrib contrib-type="author"><name><surname>Solano</surname><given-names>Olubunmi</given-names></name></contrib><contrib contrib-type="author"><name><surname>Weinberg</surname><given-names>Alison</given-names></name></contrib><contrib contrib-type="author"><name><surname>Coates</surname><given-names>Jennifer</given-names></name></contrib><contrib contrib-type="author"><name><surname>Kilroe</surname><given-names>Matthew</given-names></name></contrib><contrib contrib-type="author"><name><surname>Zernicke</surname><given-names>Lincoln</given-names></name></contrib><contrib contrib-type="author"><name><surname>Hasson</surname><given-names>Katelyn</given-names></name></contrib><contrib contrib-type="author"><name><surname>Matthew</surname><given-names>Karen</given-names></name></contrib><contrib contrib-type="author"><name><surname>Mora</surname><given-names>Samia</given-names></name></contrib><contrib contrib-type="author"><name><surname>Pfeffer</surname><given-names>Chris</given-names></name></contrib><contrib contrib-type="author"><name><surname>Duszlak</surname><given-names>Julie</given-names></name></contrib><contrib contrib-type="author"><name><surname>Bates</surname><given-names>David</given-names></name></contrib><contrib contrib-type="author"><name><surname>Guzman</surname><given-names>Vincent</given-names></name></contrib><contrib contrib-type="author"><name><surname>Falcon</surname><given-names>Josue</given-names></name></contrib><contrib contrib-type="author"><name><surname>Romero</surname><given-names>Alex</given-names></name></contrib><contrib contrib-type="author"><name><surname>Kupets</surname><given-names>Henry</given-names></name></contrib><contrib contrib-type="author"><name><surname>Cortez</surname><given-names>Frank</given-names></name></contrib><contrib contrib-type="author"><name><surname>LeSuer</surname><given-names>James C</given-names></name></contrib><contrib contrib-type="author"><name><surname>Hrbek</surname><given-names>Andrea</given-names></name></contrib><contrib contrib-type="author"><name><surname>Bowes</surname><given-names>Eileen</given-names></name></contrib><contrib contrib-type="author"><name><surname>Quinn</surname><given-names>Philomena</given-names></name></contrib><contrib contrib-type="author"><name><surname>Mele</surname><given-names>Megan</given-names></name></contrib><contrib contrib-type="author"><name><surname>Anderson</surname><given-names>Garnet L</given-names></name></contrib><contrib contrib-type="author"><name><surname>Johnson</surname><given-names>Lisa</given-names></name></contrib><contrib contrib-type="author"><name><surname>Tinker</surname><given-names>Leslie F</given-names></name></contrib><contrib contrib-type="author"><name><surname>Aragaki</surname><given-names>Aaron K</given-names></name></contrib><contrib contrib-type="author"><name><surname>Herndon</surname><given-names>Megan</given-names></name></contrib><contrib contrib-type="author"><name><surname>Mann</surname><given-names>Sue L</given-names></name></contrib><contrib contrib-type="author"><name><surname>Pettinger</surname><given-names>Mary</given-names></name></contrib><contrib contrib-type="author"><name><surname>Hunt</surname><given-names>Rebecca P</given-names></name></contrib><contrib contrib-type="author"><name><surname>Carrick</surname><given-names>Bill</given-names></name></contrib><contrib contrib-type="author"><name><surname>Szyperski</surname><given-names>Kate</given-names></name></contrib><contrib contrib-type="author"><name><surname>Proulx-Burns</surname><given-names>Lori</given-names></name></contrib><contrib contrib-type="author"><name><surname>Burrows</surname><given-names>Elizabeth</given-names></name></contrib><contrib contrib-type="author"><name><surname>Limacher</surname><given-names>Marian</given-names></name></contrib><contrib contrib-type="author"><name><surname>Hsia</surname><given-names>Judith</given-names></name></contrib><contrib contrib-type="author"><name><surname>Asaithambi</surname><given-names>Ganesh</given-names></name></contrib><contrib contrib-type="author"><name><surname>Khan</surname><given-names>Muhib</given-names></name></contrib><contrib contrib-type="author"><name><surname>Nagaraja</surname><given-names>Nandakumar</given-names></name></contrib><contrib contrib-type="author"><name><surname>Ocava</surname><given-names>Lenore C</given-names></name></contrib><contrib contrib-type="author"><name><surname>Wold</surname><given-names>Jana</given-names></name></contrib><contrib contrib-type="author"><name><surname>Silver</surname><given-names>Brian</given-names></name></contrib><contrib contrib-type="author"><name><surname>Connelly</surname><given-names>Stephanie</given-names></name></contrib><contrib contrib-type="author"><name><surname>Van Lom</surname><given-names>Gretchen</given-names></name></contrib><contrib contrib-type="author"><name><surname>Garvida</surname><given-names>Cris</given-names></name></contrib><contrib contrib-type="author"><name><surname>Hightower</surname><given-names>Kathy</given-names></name></contrib><contrib contrib-type="author"><name><surname>Spaulding</surname><given-names>Patricia</given-names></name></contrib><contrib contrib-type="author"><name><surname>Lin</surname><given-names>Wei</given-names></name></contrib><contrib contrib-type="author"><name><surname>Schoenberg</surname><given-names>Jenny</given-names></name></contrib><contrib contrib-type="author"><name><surname>Olee</surname><given-names>Patti</given-names></name></contrib><contrib contrib-type="author"><name><surname>Cohen</surname><given-names>Lawrence S</given-names></name></contrib><contrib contrib-type="author"><name><surname>Colton</surname><given-names>Theodore</given-names></name></contrib><contrib contrib-type="author"><name><surname>Henderson</surname><given-names>I Craig</given-names></name></contrib><contrib contrib-type="author"><name><surname>Hulley</surname><given-names>Stephen</given-names></name></contrib><contrib contrib-type="author"><name><surname>Lichtenstein</surname><given-names>Alice H</given-names></name></contrib><contrib contrib-type="author"><name><surname>Passamani</surname><given-names>Eugene R</given-names></name></contrib><contrib contrib-type="author"><name><surname>Silliman</surname><given-names>Rebecca A</given-names></name></contrib><contrib contrib-type="author"><name><surname>Wenger</surname><given-names>Nanette</given-names></name></contrib><contrib contrib-type="author"><name><surname>Ludlam</surname><given-names>Shari E</given-names></name></contrib><contrib contrib-type="author"><name><surname>Schroeter</surname><given-names>Hagen</given-names></name></contrib><contrib contrib-type="author"><name><surname>Fare</surname><given-names>Michael</given-names></name></contrib><contrib contrib-type="author"><name><surname>Ottawani</surname><given-names>Javier</given-names></name></contrib><contrib contrib-type="author"><name><surname>Kwik-Uribe</surname><given-names>Catherine</given-names></name></contrib><contrib contrib-type="author"><name><surname>Arnaiz</surname><given-names>Cassandra</given-names></name></contrib><contrib contrib-type="author"><name><surname>Costanza</surname><given-names>Ann</given-names></name></contrib><contrib contrib-type="author"><name><surname>Greene</surname><given-names>John</given-names></name></contrib><contrib contrib-type="author"><name><surname>Hennessey</surname><given-names>Paul</given-names></name></contrib><contrib contrib-type="author"><name><surname>Vadlamani</surname><given-names>Sarma</given-names></name></contrib><contrib contrib-type="author"><name><surname>Karmsetty</surname><given-names>Mallik</given-names></name></contrib><contrib contrib-type="author"><name><surname>Martini</surname><given-names>Paul</given-names></name></contrib><contrib contrib-type="author"><name><surname>van Klinken</surname><given-names>Jan-Willem</given-names></name></contrib><contrib contrib-type="author"><name><surname>Shah</surname><given-names>Alpa</given-names></name></contrib><contrib contrib-type="author"><name><surname>Stern</surname><given-names>Lori</given-names></name></contrib></contrib-group></collab>
                </contrib>
              </contrib-group>
              <author-notes>
                <corresp id="cor1">Address correspondence to HDS (e-mail: <email>hsesso@bwh.harvard.edu</email>)</corresp>
              </author-notes>
              <pub-date pub-type="collection">
                <month>6</month>
                <year>2022</year>
              </pub-date>
              <pub-date pub-type="epub" iso-8601-date="2022-03-16">
                <day>16</day>
                <month>3</month>
                <year>2022</year>
              </pub-date>
              <pub-date pub-type="pmc-release">
                <day>16</day>
                <month>3</month>
                <year>2022</year>
              </pub-date>
              <volume>115</volume>
              <issue>6</issue>
              <fpage>1501</fpage>
              <lpage>1510</lpage>
              <history>
                <date date-type="received">
                  <day>03</day>
                  <month>2</month>
                  <year>2022</year>
                </date>
                <date date-type="accepted">
                  <day>01</day>
                  <month>3</month>
                  <year>2022</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© The Author(s) 2022. Published by Oxford University Press on behalf of the American Society for Nutrition.</copyright-statement>
                <copyright-year>2022</copyright-year>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
              </permissions>
              <self-uri xlink:href="nqac056.pdf"/>
              <related-article related-article-type="companion" ext-link-type="doi" id="nqac055" xlink:href="10.1093/ajcn/nqac055"/>
              <abstract>
                <title>ABSTRACT</title>
                <sec id="abs1">
                  <title>Background</title>
                  <p>Although older adults commonly take multivitamin-multimineral (MVM) supplements to promote health, evidence on the use of daily MVMs on invasive cancer is limited.</p>
                </sec>
                <sec id="abs2">
                  <title>Objectives</title>
                  <p>The study objective was to determine if a daily MVM decreases total invasive cancer among older adults.</p>
                </sec>
                <sec id="abs3">
                  <title>Methods</title>
                  <p>We performed a randomized, double-blind, placebo-controlled, 2-by-2 factorial trial of a daily MVM and cocoa extract for prevention of cancer and cardiovascular disease (CVD) among 21,442 US adults (12,666 women aged ≥65 y and 8776 men aged ≥60 y) free of major CVD and recently diagnosed cancer. The intervention phase was from June 2015 through December 2020. This article reports on the MVM intervention. Participants were randomly assigned to daily MVM or placebo. The primary outcome was total invasive cancer, excluding nonmelanoma skin cancer. Secondary outcomes included major site-specific cancers, total CVD, all-cause mortality, and total cancer risk among those with a baseline history of cancer.</p>
                </sec>
                <sec id="abs4">
                  <title>Results</title>
                  <p>During a median follow-up of 3.6 y, invasive cancer occurred in 518 participants in the MVM group and 535 participants in the placebo group (HR: 0.97; 95% CI: 0.86, 1.09; <italic toggle="yes">P</italic> = 0.57). We observed no significant effect of a daily MVM on breast cancer (HR: 1.06; 95% CI: 0.79, 1.42) or colorectal cancer (HR: 1.30; 95% CI: 0.80, 2.12). We observed a protective effect of a daily MVM on lung cancer (HR: 0.62; 95% CI: 0.42, 0.92). The composite CVD outcome occurred in 429 participants in the MVM group and 437 participants in the placebo group (HR: 0.98; 95% CI: 0.86, 1.12). MVM use did not significantly affect all-cause mortality (HR: 0.93; 95% CI: 0.81, 1.08). There were no safety concerns.</p>
                </sec>
                <sec id="abs5">
                  <title>Conclusions</title>
                  <p>A daily MVM supplement, compared with placebo, did not significantly reduce the incidence of total cancer among older men and women. Future studies are needed to determine the effects of MVMs on other aging-related outcomes among older adults. This trial is registered at <ext-link xlink:href="http://www.clinicaltrials.gov" ext-link-type="uri">www.clinicaltrials.gov</ext-link> as NCT02422745.</p>
                </sec>
              </abstract>
              <kwd-group kwd-group-type="keywords">
                <kwd>multivitamin</kwd>
                <kwd>cancer</kwd>
                <kwd>randomized clinical trial</kwd>
                <kwd>cardiovascular disease</kwd>
                <kwd>cocoa extract</kwd>
                <kwd>flavanols</kwd>
              </kwd-group>
              <funding-group>
                <award-group award-type="grant">
                  <funding-source>
                    <institution-wrap>
                      <institution>COSMOS</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>AG050657</award-id>
                  <award-id>AG071611</award-id>
                  <award-id>EY025623</award-id>
                  <award-id>HL157665</award-id>
                </award-group>
                <award-group award-type="grant">
                  <funding-source>
                    <institution-wrap>
                      <institution>National Institutes of Health</institution>
                      <institution-id institution-id-type="DOI">10.13039/100000002</institution-id>
                    </institution-wrap>
                  </funding-source>
                </award-group>
                <award-group award-type="grant">
                  <funding-source>
                    <institution-wrap>
                      <institution>National Heart, Lung, and Blood Institute</institution>
                      <institution-id institution-id-type="DOI">10.13039/100000050</institution-id>
                    </institution-wrap>
                  </funding-source>
                </award-group>
                <award-group award-type="grant">
                  <funding-source>
                    <institution-wrap>
                      <institution>U.S. Department of Health and Human Services</institution>
                      <institution-id institution-id-type="DOI">10.13039/100000016</institution-id>
                    </institution-wrap>
                  </funding-source>
                  <award-id>75N92021D00001</award-id>
                  <award-id>75N92021D00002</award-id>
                  <award-id>75N92021D00003</award-id>
                  <award-id>75N92021D00004</award-id>
                  <award-id>75N92021D00005</award-id>
                </award-group>
              </funding-group>
              <counts>
                <page-count count="10"/>
              </counts>
            </article-meta>
          </front>
          <body>
            <p>See corresponding article on <ext-link xlink:href="https://doi.org/10.1093/ajcn/nqac055" ext-link-type="uri">page 1490</ext-link>.</p>
            <sec sec-type="intro" id="sec1">
              <title>Introduction</title>
              <p>Multivitamin-multimineral (MVM) formulations, which lack a universal definition (<xref rid="bib1" ref-type="bibr">1</xref>) but typically provide ≥100% of the recommended daily value of most essential vitamins and minerals (<xref rid="bib2" ref-type="bibr">2</xref>), are the most common dietary supplement taken in the United States and other high-income countries (<xref rid="bib3" ref-type="bibr">3–5</xref>). Approximately one-third of US adults report regular MVM use (<xref rid="bib3" ref-type="bibr">3</xref>, <xref rid="bib4" ref-type="bibr">4</xref>, <xref rid="bib6" ref-type="bibr">6</xref>), with an even greater prevalence among older adults (<xref rid="bib7" ref-type="bibr">7</xref>), women (<xref rid="bib8" ref-type="bibr">8</xref>), and cancer survivors (<xref rid="bib7" ref-type="bibr">7</xref>, <xref rid="bib9" ref-type="bibr">9–11</xref>). Many US adults continue to take MVMs for general health and well-being (<xref rid="bib12" ref-type="bibr">12</xref>, <xref rid="bib13" ref-type="bibr">13</xref>) or to reduce the risk of chronic diseases (<xref rid="bib14" ref-type="bibr">14</xref>) despite inconsistency among observational studies examining long-term MVM use and risk of cancer (<xref rid="bib15" ref-type="bibr">15–24</xref>) and cardiovascular disease (CVD) (<xref rid="bib18" ref-type="bibr">18</xref>, <xref rid="bib25" ref-type="bibr">25–29</xref>).</p>
              <p>Large-scale trials testing broad-based MVMs on clinical outcomes remain limited to the Physicians’ Health Study (PHS) II of 14,641 men aged ≥50 y, for which a typical MVM had a modest, significant 8% reduction in total cancer (<xref rid="bib30" ref-type="bibr">30</xref>) and no significant reductions in colorectal, lung, and bladder cancer after 11 y of follow-up. In PHS II, MVM use significantly reduced total cancer by 27% among 1312 men with a baseline history of cancer. There was a potentially stronger effect of an MVM among older men aged ≥70 y, with a significant 18% reduction in cancer (<xref rid="bib30" ref-type="bibr">30</xref>, <xref rid="bib31" ref-type="bibr">31</xref>).</p>
              <p>The persistent use of MVMs, the broad public implications of even modest efficacy on cancer and other aging-related outcomes, and the paucity of data among women warranted a new clinical trial to improve our understanding of the health effects of MVM use in older adults. Therefore, we conducted the COcoa Supplement and Multivitamin Outcomes Study (COSMOS), a large-scale, randomized, double-blind, placebo-controlled trial testing the effects of a common MVM in the prevention of cancer and CVD among women and men.</p>
            </sec>
            <sec sec-type="methods" id="sec2">
              <title>Methods</title>
              <p>The COSMOS (clinicaltrials.gov #NCT02422745) is a randomized, double-blind, placebo-controlled, 2 × 2 factorial trial testing an MVM supplement (Centrum Silver®, supplied by Pfizer Consumer Healthcare, now a part of GSK Consumer Healthcare) and cocoa extract supplement [2 capsules/d containing 500 mg cocoa flavanols/d, including 80 mg (–)-epicatechin; supplied by Mars Edge] to prevent cancer and CVD in 21,442 US adults, including 12,666 women aged ≥65 y and 8776 men aged ≥60 y who were free of myocardial infarction (MI) and stroke and recently diagnosed cancer (except for nonmelanoma skin cancer) within the past 2 y (<xref rid="bib67_1647528923391" ref-type="bibr">32</xref>). <xref rid="fig1" ref-type="fig"><bold>Figure 1</bold></xref> summarizes the overall COSMOS trial design.</p>
              <fig position="float" id="fig1">
                <label>FIGURE 1</label>
                <caption>
                  <p>Screening, randomization, and follow-up of the participants. <sup>1</sup>Eligibility was determined by medical history, age, and willingness to forego personal use of cocoa extract and multivitamin pills. <sup>2</sup>Eligibility was determined by medical history, age, willingness to forego personal use of cocoa extract and multivitamin pills, caffeine sensitivity, and willingness to limit calcium and vitamin D supplement use. <sup>3</sup>Included subjects who never completed the screening phase (<italic toggle="yes">n</italic> = 2914), eligibility could not be determined (<italic toggle="yes">n</italic> = 5), and enrollment goal already met (<italic toggle="yes">n</italic> = 55). <sup>4</sup>Included subjects who never completed screening phase (<italic toggle="yes">n</italic> = 168) and enrollment goal already met (<italic toggle="yes">n</italic> = 54).</p>
                </caption>
                <graphic xlink:href="nqac056fig1" position="float"/>
              </fig>
              <p>Briefly, an embedded recruitment approach was conducted from June 2015 to March 2018 with mailings to active participants in the Women's Health Initiative (WHI) Extension Study (<xref rid="bib32" ref-type="bibr">33</xref>), mailings by Brigham and Women's Hospital (BWH) to women and men contacted for but not randomly assigned to the VITamin D and OmegA-3 TriaL (VITAL) (<xref rid="bib33" ref-type="bibr">34</xref>), mass mailings, and mailings to volunteers who heard about the study through various sources (<bold><xref rid="sup1" ref-type="supplementary-material">Supplementary Methods</xref></bold>). To be eligible, participants agreed to forego personal MVM and cocoa extract supplement use during the trial, limit vitamin D to ≤1000 IU/d and calcium to ≤1200 mg/d from all supplemental sources, and complete at least a 2-mo placebo run-in phase taking ≥75% of the study pills. Of 191,796 participants completing a brief initial screening questionnaire, 35,669 eligible, willing, and consenting participants began a placebo run-in (<xref rid="bib34" ref-type="bibr">35</xref>).</p>
              <p>From April 2016 to March 2018, 21,442 participants meeting all eligibility requirements were randomly assigned in equal proportions to <italic toggle="yes">1</italic>) active MVM and active cocoa extract, <italic toggle="yes">2</italic>) active MVM and cocoa extract placebo, <italic toggle="yes">3</italic>) active cocoa extract and MVM placebo, or <italic toggle="yes">4</italic>) both placebos using a computer-generated permuted block approach blinded to trial investigators and stratified by sex (women, men), age (separate 5-y age groups for women and men), and recruitment source (WHI, BWH) in blocks of 12. Prior to randomization, 6867 (32.0%) of randomized participants provided biospecimens, of whom 2050 additionally provided at least 1 follow-up biospecimen at 1, 2, and/or 3 y follow-up. Mars Edge supported the measurement of 25-hydroxyvitamin D [25(OH)D], vitamin B-12, and folate concentrations in a random subset of 399 participants to evaluate compliance with the MVM intervention during follow-up.</p>
              <p>Participants received follow-up questionnaires, with calendar packs containing study pills, at 6 mo and 12 mo following randomization and semi-annually thereafter to assess compliance with randomized treatments, use of nontrial MVMs and/or cocoa supplements, potential side effects of the interventions, updated medical history, and other relevant lifestyle, clinical, and dietary risk factors. The randomized treatments continued through 31 December 2020, ending as scheduled, with a median (IQR) treatment period of 3.6 (3.2–4.2) y.</p>
              <p>All participants provided written informed consent before enrollment in the trial, and trial activities were overseen by the Human Subjects Committee at BWH/Mass General Brigham.</p>
              <sec id="sec2-1">
                <title>Primary and secondary outcomes</title>
                <p>For the MVM intervention, the primary outcome was total invasive cancer, excluding nonmelanoma skin cancer. There were 14 secondary outcomes and 4 other outcomes that mostly consisted of subtypes of CVD or cancer. Secondary outcomes included key site-specific cancers (including breast, colorectal, and lung cancer), all-cause death, a composite total CVD outcome (including incident MI, stroke, coronary revascularization, cardiovascular mortality, carotid artery surgery, peripheral artery surgery, and unstable angina requiring hospitalization), a combined outcome of CVD and all-cause mortality, and individual cardiovascular events comprising the composite total CVD outcome.</p>
                <p>Participants reporting a study outcome signed a medical record release form to request related medical records (<xref rid="bib35" ref-type="bibr">36</xref>). Outcomes were adjudicated by medical record review by a committee of physicians and trained investigators and staff blinded to treatment assignment. Incident cancers were confirmed by a pathology report that substantiated a malignant primary invasive cancer at any location other than nonmelanoma skin cancer (<xref rid="bib35" ref-type="bibr">36</xref>); all histologic types and anatomic subsites were included. Noncancerous colorectal polyps, atypical benign breast disease, in situ cancers, and other premalignant benign conditions were excluded. MI, stroke (<xref rid="bib36" ref-type="bibr">37</xref>, <xref rid="bib37" ref-type="bibr">38</xref>), coronary revascularization (<xref rid="bib35" ref-type="bibr">36</xref>), and other vascular outcomes were confirmed using established clinical criteria (see <xref rid="sup1" ref-type="supplementary-material">Supplementary Methods</xref> for details). For participants determined to be deceased, we contacted next of kin to request permission to obtain medical records and a copy of the death certificate. For WHI participants, death certificates were alternatively requested from the state where the participant died. An outcomes committee reviewed records to assign cause of death. If records were unavailable (or participants were lost to follow-up), the National Death Index Plus was searched for cause of death according to the death certificate information. Analyses included only confirmed outcomes.</p>
                <p>Throughout trial follow-up, we collected information on potential side effects and other self-reported nonmonitored outcomes such as skin cancer, colon or rectal polyps, other cardiovascular outcomes, and endocrine, metabolic, and digestive system diseases.</p>
              </sec>
              <sec id="sec2-2">
                <title>Statistical analyses</title>
                <p>Our primary analyses were based on the intention-to-treat principle for time-to-first-event data (<xref rid="bib38" ref-type="bibr">39</xref>). Cox proportional hazards models estimated HRs using an indicator variable for MVM assignment and stratifying the baseline hazard functions by sex, age group, recruitment source, and cocoa extract intervention arm. The trial was designed for 22,000 participants with ≥90% power to detect a 14% relative hazard reduction in total cancer. Models were constructed for each clinical outcome, where person-time for each outcome was counted as days from randomization to the first post-randomization diagnosis of the designated outcome. Follow-up was censored at date of last contact, death, or end of the trial on 31 December 2020, whichever came first.</p>
                <p>Kaplan-Meier cumulative incidence curves, cumulative HRs, interactions between randomization groups with trial time, and analyses that excluded the first 2 y (for cancer endpoints) or 1 y (for CVD endpoints) of follow-up assessed whether treatment effects varied over time (<xref rid="bib39" ref-type="bibr">40</xref>). Ten subgroup analyses examined effect modification by a priori (concurrent cocoa extract randomization assignment, sex, age, history of cancer, use of statins or aspirin) and post hoc (smoking status, fruit and vegetable intake at baseline, use of dietary supplements or multivitamins prior to randomization) factors. Statistical significance (<italic toggle="yes">P</italic> ≤ 0.05) was assessed with 2-sided <italic toggle="yes">P</italic> values. We did not adjust <italic toggle="yes">P</italic> values or CIs for multiple testing. Secondary outcomes mostly constituted subtypes of cancer or CVD, and numbered fewer than 20. Results for secondary and exploratory outcomes and those for subgroup analyses should therefore be interpreted with caution and considered hypothesis generating. At the nominal 0.05 level, we would expect less than 1 interaction and 1 secondary outcome to be significant by chance alone.</p>
                <p>The <bold><xref rid="sup1" ref-type="supplementary-material">Supplementary Results</xref></bold> provides details on per-protocol analyses and analyses of the blood nutrient biomarkers among a subset of individuals with baseline and follow-up blood samples. Finally, we compared self-reports of nonmonitored outcomes and potential side effects by intervention group. Analyses were performed using SAS version 9.4 (SAS Institute).</p>
              </sec>
            </sec>
            <sec sec-type="results" id="sec3">
              <title>Results</title>
              <p>A total of 21,442 individuals were randomly assigned into the COSMOS trial (<xref rid="fig1" ref-type="fig">Figure 1</xref>). The baseline characteristics of the study participants were similar between the MVM and placebo groups (<xref rid="tbl1" ref-type="table"><bold>Table 1</bold></xref> and <bold><xref rid="sup1" ref-type="supplementary-material">Supplementary Table 1</xref></bold>). The mean (SD) age of the participants was 72.1 (6.6) y and 59.1% were women. T total of 3550 (16.6%) participants had a baseline history of cancer. Prior to randomization, 41.2% reported use of an MVM, 21.4% reported consuming &gt;1000 IU vitamin D/d from supplements, 5.0% reported consuming &gt;1200 mg calcium/d from supplements, and 35.0% reported consuming &lt;4 servings of fruit and vegetables per day. A large proportion were former smokers (41.3%), although only 4.0% were current smokers.</p>
              <table-wrap position="float" id="tbl1">
                <label>TABLE 1</label>
                <caption>
                  <p>Characteristics of the participants at baseline, according to randomized assignment<sup><xref rid="tb1fn1" ref-type="table-fn">1</xref></sup></p>
                </caption>
                <table frame="hsides" rules="groups">
                  <thead>
                    <tr>
                      <th rowspan="1" colspan="1"/>
                      <th colspan="2" align="center" rowspan="1">Total (<italic toggle="yes">n</italic> = 21,442)</th>
                      <th colspan="2" align="center" rowspan="1">Multivitamin (<italic toggle="yes">n</italic> = 10,720)</th>
                      <th colspan="2" align="center" rowspan="1">Placebo (<italic toggle="yes">n</italic> = 10,722)</th>
                    </tr>
                    <tr>
                      <th rowspan="1" colspan="1"/>
                      <th align="left" rowspan="1" colspan="1">
                        <italic toggle="yes">n</italic>
                      </th>
                      <th align="left" rowspan="1" colspan="1">(%)</th>
                      <th align="left" rowspan="1" colspan="1">
                        <italic toggle="yes">n</italic>
                      </th>
                      <th align="left" rowspan="1" colspan="1">(%)</th>
                      <th align="left" rowspan="1" colspan="1">
                        <italic toggle="yes">n</italic>
                      </th>
                      <th align="left" rowspan="1" colspan="1">(%)</th>
                    </tr>
                  </thead>
                  <tbody>
                    <tr>
                      <td rowspan="1" colspan="1">Female sex</td>
                      <td rowspan="1" colspan="1">12,666</td>
                      <td rowspan="1" colspan="1">(59.1)</td>
                      <td rowspan="1" colspan="1">6338</td>
                      <td rowspan="1" colspan="1">(59.1)</td>
                      <td rowspan="1" colspan="1">6328</td>
                      <td rowspan="1" colspan="1">(59.0)</td>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1">Age, mean ± SD, y</td>
                      <td colspan="2" align="center" rowspan="1">72.1± 6.6</td>
                      <td colspan="2" align="center" rowspan="1">72.1± 6.6</td>
                      <td colspan="2" align="center" rowspan="1">72.1± 6.6</td>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1">Hispanic/Latino<sup><xref rid="tb1fn2" ref-type="table-fn">2</xref></sup></td>
                      <td rowspan="1" colspan="1">544</td>
                      <td rowspan="1" colspan="1">(2.6)</td>
                      <td rowspan="1" colspan="1">284</td>
                      <td rowspan="1" colspan="1">(2.8)</td>
                      <td rowspan="1" colspan="1">260</td>
                      <td rowspan="1" colspan="1">(2.5)</td>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1">Race<sup><xref rid="tb1fn2" ref-type="table-fn">2</xref></sup></td>
                      <td rowspan="1" colspan="1"/>
                      <td rowspan="1" colspan="1"/>
                      <td rowspan="1" colspan="1"/>
                      <td rowspan="1" colspan="1"/>
                      <td rowspan="1" colspan="1"/>
                      <td rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1"> White</td>
                      <td rowspan="1" colspan="1">19,294</td>
                      <td rowspan="1" colspan="1">(90.0)</td>
                      <td rowspan="1" colspan="1">9628</td>
                      <td rowspan="1" colspan="1">(89.8)</td>
                      <td rowspan="1" colspan="1">9666</td>
                      <td rowspan="1" colspan="1">(90.2)</td>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1"> African American</td>
                      <td rowspan="1" colspan="1">1131</td>
                      <td rowspan="1" colspan="1">(5.3)</td>
                      <td rowspan="1" colspan="1">568</td>
                      <td rowspan="1" colspan="1">(5.3)</td>
                      <td rowspan="1" colspan="1">563</td>
                      <td rowspan="1" colspan="1">(5.3)</td>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1"> Asian/Pacific Islander</td>
                      <td rowspan="1" colspan="1">499</td>
                      <td rowspan="1" colspan="1">(2.3)</td>
                      <td rowspan="1" colspan="1">258</td>
                      <td rowspan="1" colspan="1">(2.4)</td>
                      <td rowspan="1" colspan="1">241</td>
                      <td rowspan="1" colspan="1">(2.2)</td>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1"> American Indian/Alaska Native</td>
                      <td rowspan="1" colspan="1">59</td>
                      <td rowspan="1" colspan="1">(0.3)</td>
                      <td rowspan="1" colspan="1">37</td>
                      <td rowspan="1" colspan="1">(0.3)</td>
                      <td rowspan="1" colspan="1">22</td>
                      <td rowspan="1" colspan="1">(0.2)</td>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1"> Multiracial/other/unknown or not reported</td>
                      <td rowspan="1" colspan="1">459</td>
                      <td rowspan="1" colspan="1">(2.1)</td>
                      <td rowspan="1" colspan="1">229</td>
                      <td rowspan="1" colspan="1">(2.1)</td>
                      <td rowspan="1" colspan="1">230</td>
                      <td rowspan="1" colspan="1">(2.1)</td>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1">Education</td>
                      <td rowspan="1" colspan="1"/>
                      <td rowspan="1" colspan="1"/>
                      <td rowspan="1" colspan="1"/>
                      <td rowspan="1" colspan="1"/>
                      <td rowspan="1" colspan="1"/>
                      <td rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1"> High school diploma/GED or less</td>
                      <td rowspan="1" colspan="1">2296</td>
                      <td rowspan="1" colspan="1">(10.8)</td>
                      <td rowspan="1" colspan="1">1180</td>
                      <td rowspan="1" colspan="1">(11.1)</td>
                      <td rowspan="1" colspan="1">1116</td>
                      <td rowspan="1" colspan="1">(10.5)</td>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1"> Attended or graduated from college</td>
                      <td rowspan="1" colspan="1">8685</td>
                      <td rowspan="1" colspan="1">(40.9)</td>
                      <td rowspan="1" colspan="1">4315</td>
                      <td rowspan="1" colspan="1">(40.7)</td>
                      <td rowspan="1" colspan="1">4370</td>
                      <td rowspan="1" colspan="1">(41.1)</td>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1"> Post-college</td>
                      <td rowspan="1" colspan="1">10,241</td>
                      <td rowspan="1" colspan="1">(48.3)</td>
                      <td rowspan="1" colspan="1">5104</td>
                      <td rowspan="1" colspan="1">(48.2)</td>
                      <td rowspan="1" colspan="1">5137</td>
                      <td rowspan="1" colspan="1">(48.4)</td>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1">Smoking status</td>
                      <td rowspan="1" colspan="1"/>
                      <td rowspan="1" colspan="1"/>
                      <td rowspan="1" colspan="1"/>
                      <td rowspan="1" colspan="1"/>
                      <td rowspan="1" colspan="1"/>
                      <td rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1"> Never</td>
                      <td rowspan="1" colspan="1">11,565</td>
                      <td rowspan="1" colspan="1">(54.7)</td>
                      <td rowspan="1" colspan="1">5808</td>
                      <td rowspan="1" colspan="1">(54.9)</td>
                      <td rowspan="1" colspan="1">5757</td>
                      <td rowspan="1" colspan="1">(54.5)</td>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1"> Past</td>
                      <td rowspan="1" colspan="1">8731</td>
                      <td rowspan="1" colspan="1">(41.3)</td>
                      <td rowspan="1" colspan="1">4345</td>
                      <td rowspan="1" colspan="1">(41.1)</td>
                      <td rowspan="1" colspan="1">4386</td>
                      <td rowspan="1" colspan="1">(41.5)</td>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1"> Current</td>
                      <td rowspan="1" colspan="1">835</td>
                      <td rowspan="1" colspan="1">(4.0)</td>
                      <td rowspan="1" colspan="1">417</td>
                      <td rowspan="1" colspan="1">(3.9)</td>
                      <td rowspan="1" colspan="1">418</td>
                      <td rowspan="1" colspan="1">(4.0)</td>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1">Multivitamin use before run-in</td>
                      <td rowspan="1" colspan="1">8795</td>
                      <td rowspan="1" colspan="1">(41.2)</td>
                      <td rowspan="1" colspan="1">4413</td>
                      <td rowspan="1" colspan="1">(41.3)</td>
                      <td rowspan="1" colspan="1">4382</td>
                      <td rowspan="1" colspan="1">(41.0)</td>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1">Vitamin D from supplements before run-in</td>
                      <td rowspan="1" colspan="1"/>
                      <td rowspan="1" colspan="1"/>
                      <td rowspan="1" colspan="1"/>
                      <td rowspan="1" colspan="1"/>
                      <td rowspan="1" colspan="1"/>
                      <td rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1"> None</td>
                      <td rowspan="1" colspan="1">7960</td>
                      <td rowspan="1" colspan="1">(37.6)</td>
                      <td rowspan="1" colspan="1">4012</td>
                      <td rowspan="1" colspan="1">(37.9)</td>
                      <td rowspan="1" colspan="1">3948</td>
                      <td rowspan="1" colspan="1">(37.3)</td>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1"> ≤1000 IU/d</td>
                      <td rowspan="1" colspan="1">8670</td>
                      <td rowspan="1" colspan="1">(41.0)</td>
                      <td rowspan="1" colspan="1">4331</td>
                      <td rowspan="1" colspan="1">(40.9)</td>
                      <td rowspan="1" colspan="1">4339</td>
                      <td rowspan="1" colspan="1">(41.0)</td>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1"> &gt;1000 IU/d</td>
                      <td rowspan="1" colspan="1">4536</td>
                      <td rowspan="1" colspan="1">(21.4)</td>
                      <td rowspan="1" colspan="1">2238</td>
                      <td rowspan="1" colspan="1">(21.2)</td>
                      <td rowspan="1" colspan="1">2298</td>
                      <td rowspan="1" colspan="1">(21.7)</td>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1">Calcium from supplements before run-in</td>
                      <td rowspan="1" colspan="1"/>
                      <td rowspan="1" colspan="1"/>
                      <td rowspan="1" colspan="1"/>
                      <td rowspan="1" colspan="1"/>
                      <td rowspan="1" colspan="1"/>
                      <td rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1"> None</td>
                      <td rowspan="1" colspan="1">10,917</td>
                      <td rowspan="1" colspan="1">(51.5)</td>
                      <td rowspan="1" colspan="1">5483</td>
                      <td rowspan="1" colspan="1">(51.8)</td>
                      <td rowspan="1" colspan="1">5434</td>
                      <td rowspan="1" colspan="1">(51.3)</td>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1"> ≤1200 mg/d</td>
                      <td rowspan="1" colspan="1">9200</td>
                      <td rowspan="1" colspan="1">(43.4)</td>
                      <td rowspan="1" colspan="1">4596</td>
                      <td rowspan="1" colspan="1">(43.4)</td>
                      <td rowspan="1" colspan="1">4604</td>
                      <td rowspan="1" colspan="1">(43.5)</td>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1"> &gt;1200 mg/d</td>
                      <td rowspan="1" colspan="1">1066</td>
                      <td rowspan="1" colspan="1">(5.0)</td>
                      <td rowspan="1" colspan="1">516</td>
                      <td rowspan="1" colspan="1">(4.9)</td>
                      <td rowspan="1" colspan="1">550</td>
                      <td rowspan="1" colspan="1">(5.2)</td>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1">History of diabetes</td>
                      <td rowspan="1" colspan="1">2864</td>
                      <td rowspan="1" colspan="1">(13.4)</td>
                      <td rowspan="1" colspan="1">1415</td>
                      <td rowspan="1" colspan="1">(13.2)</td>
                      <td rowspan="1" colspan="1">1449</td>
                      <td rowspan="1" colspan="1">(13.5)</td>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1">History of high blood pressure</td>
                      <td rowspan="1" colspan="1">12,423</td>
                      <td rowspan="1" colspan="1">(58.1)</td>
                      <td rowspan="1" colspan="1">6153</td>
                      <td rowspan="1" colspan="1">(57.6)</td>
                      <td rowspan="1" colspan="1">6270</td>
                      <td rowspan="1" colspan="1">(58.6)</td>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1">Statin use</td>
                      <td rowspan="1" colspan="1">8911</td>
                      <td rowspan="1" colspan="1">(42.1)</td>
                      <td rowspan="1" colspan="1">4464</td>
                      <td rowspan="1" colspan="1">(42.2)</td>
                      <td rowspan="1" colspan="1">4447</td>
                      <td rowspan="1" colspan="1">(41.9)</td>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1">Aspirin use</td>
                      <td rowspan="1" colspan="1">10,379</td>
                      <td rowspan="1" colspan="1">(48.9)</td>
                      <td rowspan="1" colspan="1">5168</td>
                      <td rowspan="1" colspan="1">(48.7)</td>
                      <td rowspan="1" colspan="1">5211</td>
                      <td rowspan="1" colspan="1">(49.1)</td>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1">History of revascularization (CABG/PCI)</td>
                      <td rowspan="1" colspan="1">862</td>
                      <td rowspan="1" colspan="1">(4.0)</td>
                      <td rowspan="1" colspan="1">426</td>
                      <td rowspan="1" colspan="1">(4.0)</td>
                      <td rowspan="1" colspan="1">436</td>
                      <td rowspan="1" colspan="1">(4.1)</td>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1">History of unstable angina</td>
                      <td rowspan="1" colspan="1">374</td>
                      <td rowspan="1" colspan="1">(1.8)</td>
                      <td rowspan="1" colspan="1">194</td>
                      <td rowspan="1" colspan="1">(1.8)</td>
                      <td rowspan="1" colspan="1">180</td>
                      <td rowspan="1" colspan="1">(1.7)</td>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1">History of carotid artery surgery/stenting</td>
                      <td rowspan="1" colspan="1">93</td>
                      <td rowspan="1" colspan="1">(0.4)</td>
                      <td rowspan="1" colspan="1">44</td>
                      <td rowspan="1" colspan="1">(0.4)</td>
                      <td rowspan="1" colspan="1">49</td>
                      <td rowspan="1" colspan="1">(0.5)</td>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1">History of peripheral artery surgery/stenting</td>
                      <td rowspan="1" colspan="1">144</td>
                      <td rowspan="1" colspan="1">(0.7)</td>
                      <td rowspan="1" colspan="1">81</td>
                      <td rowspan="1" colspan="1">(0.8)</td>
                      <td rowspan="1" colspan="1">63</td>
                      <td rowspan="1" colspan="1">(0.6)</td>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1">History of heart failure</td>
                      <td rowspan="1" colspan="1">364</td>
                      <td rowspan="1" colspan="1">(1.7)</td>
                      <td rowspan="1" colspan="1">188</td>
                      <td rowspan="1" colspan="1">(1.8)</td>
                      <td rowspan="1" colspan="1">176</td>
                      <td rowspan="1" colspan="1">(1.7)</td>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1">History of cancer excluding nonmelanoma skin cancer</td>
                      <td rowspan="1" colspan="1">3550</td>
                      <td rowspan="1" colspan="1">(16.6)</td>
                      <td rowspan="1" colspan="1">1813</td>
                      <td rowspan="1" colspan="1">(16.9)</td>
                      <td rowspan="1" colspan="1">1737</td>
                      <td rowspan="1" colspan="1">(16.2)</td>
                    </tr>
                  </tbody>
                </table>
                <table-wrap-foot>
                  <fn id="tb1fn1">
                    <label>1</label>
                    <p><italic toggle="yes">n</italic> = 21,442. Percentages may not sum to 100 because of rounding. Data on age and sex were complete. Data on other characteristics were available for ≥98.5% of the trial participants. Multivitamin refers to multivitamin-multimineral which was tested in COSMOS. CABG/PCI, coronary artery bypass graft and percutaneous coronary intervention; COSMOS, COcoa Supplement and Multivitamin Outcomes Study; GED, General Educational Development.</p>
                  </fn>
                  <fn id="tb1fn2">
                    <label>2</label>
                    <p>Ethnic group and race were self-reported by participants. Multiracial participants self-identified with &gt;1 race. Participants of other race or unknown race self-identified with those categories.</p>
                  </fn>
                </table-wrap-foot>
              </table-wrap>
              <p>The mean follow-up time was 3.6 y (IQR: 3.2–4.2 y), with a total of 77,331 person-years of follow-up. The primary outcome of invasive cancer was confirmed in 1053 participants, including 180 cases of breast cancer (among women only), 67 cases of colorectal cancer, 107 cases of lung cancer, 206 cases of prostate cancer (among men only), and 74 cases of melanoma during the trial period. The annualized rates of total invasive cancer were 1.37% and 1.42% in the MVM and placebo groups, respectively. We observed no significant effect on the primary outcome of total invasive cancer (HR: 0.97; 95% CI: 0.86, 1.09) (<xref rid="fig2" ref-type="fig"><bold>Figure 2</bold></xref>). The cumulative incidence curves for the MVM group and placebo groups were similar (log-rank <italic toggle="yes">P</italic> = 0.57) (<xref rid="fig3" ref-type="fig"><bold>Figure 3</bold></xref>), as were the cumulative HRs (<bold><xref rid="sup1" ref-type="supplementary-material">Supplementary Figure 1</xref></bold>). When we excluded the first 2 y of follow-up to account for cancer latency, we observed no significant effect on the risk of invasive cancer for the MVM group compared with the placebo group (HR: 0.93; 95% CI: 0.77, 1.11).</p>
              <fig position="float" id="fig2">
                <label>FIGURE 2</label>
                <caption>
                  <p>HRs and 95% CIs<sup>1</sup> for the primary and secondary cancer outcomes, according to randomized assignment, in intention-to-treat analyses. <sup>1</sup>Summary statistics were from Cox regression models that stratified baseline hazard functions by cocoa extract trial randomization group, age, sex, and recruitment cohort. Analyses were not adjusted for multiple comparisons. <sup>2</sup>This outcome was a composite of invasive cancers of any site other than nonmelanoma skin cancer.</p>
                </caption>
                <graphic xlink:href="nqac056fig2" position="float"/>
              </fig>
              <fig position="float" id="fig3">
                <label>FIGURE 3</label>
                <caption>
                  <p>Cumulative incidence rates of invasive cancer events,<sup>1</sup> according to year of follow-up, in multivitamin group and placebo group. <sup>1</sup>Primary outcome: a composite of invasive cancers of any site other than nonmelanoma skin cancer. Summary statistics were from Cox regression models that stratified baseline hazard functions by cocoa extract trial randomization group, age, sex, and recruitment cohort (intention-to-treat analyses). <italic toggle="yes">P</italic> value was for the effect of randomization group, based on a stratified score (log-rank) test.</p>
                </caption>
                <graphic xlink:href="nqac056fig3" position="float"/>
              </fig>
              <p>We found no significant effect of a daily MVM on breast cancer (HR: 1.06; 95% CI: 0.79, 1.42), colorectal cancer (HR: 1.30; 95% CI: 0.80, 2.12), prostate cancer (HR: 0.82; 95% CI: 0.62, 1.08), or melanoma (HR: 0.86; 95% CI: 0.54, 1.35) (<xref rid="fig2" ref-type="fig">Figure 2</xref>). However, a daily MVM significantly reduced lung cancer compared with placebo (HR: 0.62; 95% CI: 0.42, 0.92) (<xref rid="fig2" ref-type="fig">Figure 2</xref>). We observed 225 cancer deaths during the trial, including 116 in the MVM group and 109 in the placebo group (HR: 1.06; 95% CI: 0.82, 1.38) (<xref rid="fig2" ref-type="fig">Figure 2</xref>). We did not observe a significant association between MVM use and all-cause mortality (HR: 0.93; 95% CI: 0.81, 1.08) or CVD mortality (HR: 0.87; 95% CI: 0.65, 1.17) (<xref rid="fig2" ref-type="fig">Figure 2</xref> and <xref rid="fig4" ref-type="fig"><bold>Figure 4</bold></xref>).</p>
              <fig position="float" id="fig4">
                <label>FIGURE 4</label>
                <caption>
                  <p>HRs and 95% CIs<sup>1</sup> for secondary cardiovascular disease outcomes, according to randomized assignment, in intention-to-treat analyses. <sup>1</sup>Summary statistics were from Cox regression models that stratified baseline hazard functions by cocoa extract trial randomization group, age, sex, and recruitment cohort. Analyses were not adjusted for multiple comparisons. <sup>2</sup>This outcome was a composite of myocardial infarction, stroke, cardiovascular death, CABG/PCI, unstable angina including hospitalization, carotid artery surgery, and peripheral artery surgery or angioplasty. <sup>3</sup>This outcome was a composite of myocardial infarction, stroke, and cardiovascular death. CABG/PCI, coronary artery bypass graft and percutaneous coronary intervention; CVD, cardiovascular disease.</p>
                </caption>
                <graphic xlink:href="nqac056fig4" position="float"/>
              </fig>
              <p>Results from the subgroup analyses for total invasive cancer are presented in <bold><xref rid="sup1" ref-type="supplementary-material">Supplementary Figure 2</xref></bold>. We did not find significant effect modification by any of the variables examined. Among 3550 participants with a baseline history of cancer, MVM use had no significant effect on total invasive cancer compared with placebo (HR: 0.97; 95% CI: 0.77, 1.23), and the effect was similar among those without a baseline history of cancer (HR: 0.97; 95% CI: 0.84, 1.11). There was a trend towards a lower risk of cancer among those who ever smoked (HR: 0.86; 95% CI: 0.72, 1.02), but this difference was not significantly different from that among never-smokers (HR: 1.08; 95% CI: 0.91, 1.28) (<italic toggle="yes">P</italic>-interaction = 0.06).</p>
              <p>To facilitate comparison with the findings from PHS II, we performed sex-stratified analyses for total invasive cancer. MVM use was not associated with a significant reduction in the risk of total invasive cancer among men (HR: 0.94; 95% CI: 0.78, 1.13) or women (HR: 0.98; 95% CI: 0.84, 1.15) (<italic toggle="yes">P</italic>-interaction = 0.74) (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure 2</xref>).</p>
              <p>Among participants who completed questionnaires assessing compliance, the percentage of participants who reported abstaining from use of nonstudy multivitamin supplements, abstaining from use of nonstudy vitamin D supplements &gt;1000 IU/d, or having missed ≤8 d of MVM pills per month was &gt;80% at 12, 24, and 36 mo and study closeout (<bold><xref rid="sup1" ref-type="supplementary-material">Supplementary Figure 3</xref></bold>). When we additionally considered those who did not return questionnaires to be noncompliant, total compliance among those taking active MVM compared with placebo was 71.0% and 68.6% at 36 mo (90.8% of randomized participants). Using our most restrictive definition of noncompliance, which incorporated compliance to both study-related pills, vitamin D intake, and follow-up questionnaires, analyses censoring at first report of noncompliance for total (HR: 0.97; 95% CI: 0.84, 1.12) and site-specific cancers paralleled the findings of our primary analyses (<bold><xref rid="sup1" ref-type="supplementary-material">Supplementary Figure 4</xref></bold>).</p>
              <p>Among 399 participants with baseline and follow-up measures of serum 25(OH)D, vitamin B-12, and folate, concentrations of these biomarkers were balanced between the arms at baseline (<xref rid="sup1" ref-type="supplementary-material">Supplementary Table 1</xref>). Compared with the placebo group, the multivitamin group had significantly greater increases in serum 25(OH)D, vitamin B-12, and folate (<bold><xref rid="sup1" ref-type="supplementary-material">Supplementary Figures 5–7</xref></bold>; <xref rid="sup1" ref-type="supplementary-material">Supplementary Results</xref>).</p>
              <p>Our secondary outcome of total CVD occurred in 866 individuals, including 189 first events of MI, 237 cases of stroke, 180 cases of cardiovascular death, 341 cases of coronary revascularization, 92 cases of unstable angina requiring hospitalization, 52 cases of carotid artery disease, and 36 cases of peripheral artery disease, with some participants experiencing multiple events. The annual event rates were 1.13% and 1.15% in the MVM and placebo groups, respectively. A daily MVM had no significant effect on total CVD (HR: 0.98; 95% CI: 0.86, 1.12) compared with placebo, which also extended to individual cardiovascular outcomes (<xref rid="fig4" ref-type="fig">Figure 4</xref>) and the combined outcome of CVD and all-cause mortality (HR: 0.95; 95% CI: 0.86, 1.06). Latency analyses excluding the first year of follow-up did not materially alter the findings for total CVD (HR: 1.02), all-cause mortality (HR: 0.92), or total CVD and all-cause mortality (HR: 0.95).</p>
              <p>Those assigned to the active MVM had lower rates of self-reported stomach upset or pain (HR: 0.94; 95% CI: 0.90, 0.98), diarrhea (HR: 0.93; 95% CI: 0.90, 0.96), skin rash (HR: 0.95; 95% CI: 0.90, 0.99), and easy bruising (HR: 0.94; 95% CI: 0.90, 0.98) and a higher rate of gastrointestinal bleeding (HR: 1.17; 95% CI: 1.03, 1.32) compared with the placebo group. We found no other significant differences between the MVM and placebo groups for all other potential side effects or self-reported nonmonitored study outcomes (<bold><xref rid="sup1" ref-type="supplementary-material">Supplementary Figures 8</xref></bold> and <bold><xref rid="sup1" ref-type="supplementary-material">9</xref></bold>).</p>
            </sec>
            <sec sec-type="discussion" id="sec4">
              <title>Discussion</title>
              <p>In this large-scale, randomized, placebo-controlled trial in older women and men with high compliance and follow-up, a daily MVM did not reduce the primary outcome of total invasive cancer. The lack of a significant effect of an MVM extended to those with a baseline history of cancer, in contrast to previous findings in men from PHS II (<xref rid="bib30" ref-type="bibr">30</xref>). In addition, MVM supplementation had no significant effect on the secondary outcomes of total cardiovascular events, CVD death, or all-cause mortality.</p>
              <p>A 2014 systematic review (<xref rid="bib40" ref-type="bibr">41</xref>) and recommendation by the US Preventive Services Task Force (USPSTF) concluded that “the current evidence is insufficient to assess the balance of benefits and harms of multivitamins for the prevention of cardiovascular disease and cancer” (<xref rid="bib41" ref-type="bibr">42</xref>). The USPSTF recently updated their systematic review (<xref rid="bib42" ref-type="bibr">43</xref>) for new recommendations prior to the completion of COSMOS and these forthcoming recommendations should integrate the COSMOS trial results. Meanwhile, 70% of US adults aged ≥60 y take at least 1 dietary supplement daily (<xref rid="bib8" ref-type="bibr">8</xref>), with MVMs remaining the most frequently used dietary supplement (<xref rid="bib3" ref-type="bibr">3</xref>, <xref rid="bib4" ref-type="bibr">4</xref>), although use differs by socioeconomic and health-related factors (<xref rid="bib43" ref-type="bibr">44</xref>) and MVMs are more likely to be used by those with a healthy lifestyle and diet (<xref rid="bib44" ref-type="bibr">45</xref>). Therefore, there are major public health implications regarding MVM use in terms of perceived benefits and financial burden, with billions of dollars in annual global dietary supplement sales (<xref rid="bib45" ref-type="bibr">46</xref>).</p>
              <p>Individual vitamins and minerals may reduce cancer risk by protecting against free-radical damage and oxidation (<xref rid="bib46" ref-type="bibr">47</xref>, <xref rid="bib47" ref-type="bibr">48</xref>), enhancing immune response (<xref rid="bib48" ref-type="bibr">49</xref>, <xref rid="bib49" ref-type="bibr">50</xref>), blocking the formation of carcinogenic nitrosamines (<xref rid="bib50" ref-type="bibr">51</xref>), and modulating tumor growth (<xref rid="bib47" ref-type="bibr">48</xref>, <xref rid="bib51" ref-type="bibr">52</xref>, <xref rid="bib52" ref-type="bibr">53</xref>). However, an MVM cannot necessarily replicate the natural interactions of vitamins, minerals, and bioactive components in foods reflecting healthy dietary patterns, which are inversely associated with cancer (<xref rid="bib53" ref-type="bibr">54</xref>, <xref rid="bib54" ref-type="bibr">55</xref>) and CVD (<xref rid="bib55" ref-type="bibr">56</xref>, <xref rid="bib56" ref-type="bibr">57</xref>). Observational studies of MVM use and risk of cancer and CVD have been inconclusive (<xref rid="bib41" ref-type="bibr">42</xref>, <xref rid="bib57" ref-type="bibr">58</xref>), likely reflecting uncontrolled confounding and selection bias. Further, it is important to consider the effect of an MVM on both total and individual cancer sites given the heterogeneity of cancer etiology and risk factors. In the Cancer Prevention Study II in more than 1 million US adults, MVM use was not associated with cancer mortality (<xref rid="bib58" ref-type="bibr">59</xref>) but was inversely associated with incident colon cancer (<xref rid="bib59" ref-type="bibr">60</xref>) and total mortality (<xref rid="bib20" ref-type="bibr">20</xref>). Increasing duration of MVM use was inversely associated with colon cancer in the Nurses’ Health Study (<xref rid="bib21" ref-type="bibr">21</xref>). However, there was little or no association between personal MVM use and risk of breast, colon, or other cancers in more than 160,000 WHI women followed for 8 y (<xref rid="bib18" ref-type="bibr">18</xref>).</p>
              <p>We tested a commonly used MVM with previously demonstrated safety in PHS II (<xref rid="bib30" ref-type="bibr">30</xref>, <xref rid="bib31" ref-type="bibr">31</xref>), which included essential vitamins and minerals plus newly added lutein and lycopene (<bold><xref rid="sup1" ref-type="supplementary-material">Supplementary Table 2</xref></bold>). PHS II is the only other completed trial of a broad-based MVM among male physicians aged ≥50 y, with a longer median follow-up of 11 y, finding a modest, significant 8% reduction in total cancer (<xref rid="bib30" ref-type="bibr">30</xref>). In COSMOS, we observed no significant association between MVM use and invasive cancer among men. Two-year latency analyses showed similar findings to the overall results, although power for these analyses was limited. Further, we found significant 38% reductions in lung cancer in COSMOS. However, PHS II did not observe a statistically significant association between MVM use and lung cancer. Among 3550 women and men in COSMOS with a baseline history of cancer, we did not replicate the significant 27% reduction on total cancer in PHS II. Despite a stronger 18% reduction in cancer among men aged ≥70 y in PHS II (<xref rid="bib31" ref-type="bibr">31</xref>), COSMOS found no significant effect modification between MVM use and age on total cancer. Finally, in COSMOS, we found a similar lack of effect for an MVM on total CVD as in PHS II. Although both PHS II and COSMOS tested a common MVM, changes were made to the formulation between the 2 trials (<xref rid="sup1" ref-type="supplementary-material">Supplementary Table 2</xref>). We cannot directly determine whether differences in MVM formulations, along with other study design modifications, explain any differences in COSMOS compared with PHS II results.</p>
              <p>Earlier supplement trials tested limited combinations of vitamins and minerals in contrast to COSMOS and PHS II. The Linxian trial tested a combination of β-carotene, vitamin E, and selenium for 6 y in 29,584 adults in rural China and found significant reductions of 9%, 13%, and 21% in mortality, cancer mortality, and gastric cancer mortality, respectively (<xref rid="bib60" ref-type="bibr">61</xref>), which remained after 10 y of post-trial follow-up (<xref rid="bib61" ref-type="bibr">62</xref>). The Heart Protection Study in 20,536 adults in the United Kingdom tested higher doses of the same nutrients but found no reductions in total or site-specific cancer or CVD during a mean follow-up of 5 y (<xref rid="bib62" ref-type="bibr">63</xref>). Finally, the SU.VI.MAX trial randomly assigned 13,017 subjects to vitamin C, vitamin E, β-carotene, selenium, and zinc, with no overall effect on total cancer incidence or cancer mortality during a median follow-up of 7.5 y; however, they did observe a 31% decrease in total cancer incidence and a 37% decrease in cancer mortality in men only (<xref rid="bib63" ref-type="bibr">64</xref>). Our placebo-controlled trial of a broad-based MVM cannot be extrapolated to the effects of individual nutrients or other MVM formulations.</p>
              <p>Baseline nutritional status is another important consideration, as COSMOS participants may already have adequate or optimum nutrient intake for which MVM supplementation may offer limited benefits (<xref rid="bib64" ref-type="bibr">65</xref>), whereas nutritionally vulnerable populations may improve nutritional status with broad-based MVMs (<xref rid="bib57" ref-type="bibr">58</xref>, <xref rid="bib65" ref-type="bibr">66</xref>). We plan to expand evaluations of randomized MVM use, dietary status, changes in nutritional biomarkers, and cancer and CVD risk.</p>
              <p>The COSMOS trial has several key strengths, including the enrollment of a large, older population of US adults with high rates of follow-up and compliance and medical record–adjudicated primary and secondary cancer and CVD outcomes. Utilizing a hybrid trial design (<xref rid="bib66" ref-type="bibr">67</xref>), several ancillary studies are examining the effect of an MVM on cognition, eye health, changes in aging-related biomarkers, falls, and other clinically relevant outcomes to help us understand the overall balance of risks and benefits for MVM supplementation. Finally, we tested a commonly used MVM supplement to ensure broader generalizability of our findings.</p>
              <p>Several limitations should be considered when interpreting our findings. First, the COSMOS intervention was relatively short to detect a potential small-to-moderate effect on cancer outcomes given the long duration of time typically required for nutritional interventions to potentially reduce cancer risk. Due to the short duration of COSMOS, we were unable to explore the impact of longer latency periods on our findings. Post-intervention follow-up for COSMOS may help clarify any longer-term effects on cancer, all-cause mortality, and other outcomes. Second, our secondary and exploratory analyses should be interpreted with caution, especially given an overall lack of effect of an MVM on the primary outcome of total invasive cancer. Third, we successfully leveraged existing cohorts with mass mailings to expedite recruitment and randomization of 21,442 participants into COSMOS. However, generalizability may be limited, with modest diversity of 10% non-Whites and 2.6% Hispanics plus healthy volunteer bias for participants willing and eligible to enroll in a mail-based clinical trial.</p>
              <p>In conclusion, MVM supplementation did not reduce our primary outcome of total invasive cancer after 3.6 y of treatment in older women and men. MVM use also had no effect on cancer among those with a baseline history of cancer or on the secondary outcomes of total CVD. These findings do not support the regular use of MVMs for cancer or CVD prevention among generally healthy older men and women. Future studies should clarify the role of long-term MVM use on nutritional status and the balance of risks and benefits on cancer, CVD, and other aging-related outcomes.</p>
            </sec>
            <sec sec-type="supplementary-material">
              <title>Supplementary Material</title>
              <supplementary-material id="sup1" position="float" content-type="local-data">
                <label>nqac056_Supplemental_File</label>
                <media xlink:href="nqac056_supplemental_file.docx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
            </sec>
          </body>
          <back>
            <ack id="ack1">
              <title>Acknowledgments</title>
              <p>COSMOS Research Group Participants</p>
              <p>Brigham and Women's Hospital: Principal Investigators, JoAnn E Manson, Howard D Sesso; Co-Investigators, Pamela M Rist, Susanne Rautiainen Lagerstrom, Shari S Bassuk, Lu Wang, Aditi Hazra, Heike Gibson, Meryl S LeBoff, Samia Mora, Olivia I Okereke, Deirdre K Tobias, Nancy R Cook, Paulette D Chandler, William Christen; Study Managers/Coordinators, Georgina Friedenberg, Trisha Copeland, Jasmah Hanna, Allison Clar, Denise D'Agostino; Statisticians/Analysts, Manickavasagar Vinayagamoorthy, Heike Gibson, Eunjung Kim, Martin Van Denburgh, Gregory Kotler, Chunying Li, Vadim Bubes; Programmers, Ara Sarkissian, Doug Smith, Eduardo C Pereira, Melvyn Okeke, Elise Roche, David Bates, Claire Ridge; Research Assistants, Alexandra Phillips, Brielle Salvo, Annalee Wilson, Leah Hall, Jimaldy Baez, Young-Hwan Sim, Hayara Cardoso, Gabriel Senor, Connor Rudnicki, Hanh Huynh, Viviane Nguyen, Nicholas Terrell; Outcomes, Beth A Holman, Joseph Walter, Lisa Fields Johnson, Amy Casarella, Julia O'Connell; Outcome Adjudicators, William Christen, Susanne Rautiainen Lagerstrom, Luc Djoussé, Paulette D Chandler, Aditi Hazra, Deidre K Tobias, Zareen M Farukhi, Lu Wang, Xuehong Zhang; Mailings/Processing, Kenneth Breen, George V Menjin Jr, Rolando Rodriguez, Shamikhah Curry; Safety Oversight, Samia Mora; Clinic Research Assistants, Leah Arsenault, Olubunmi Solano, Alison Weinberg, Jennifer Coates, Matthew Kilroe, Lincoln Zernicke, Katelyn Hasson, Karen Matthew; Lab, Samia Mora, Chris Pfeffer, Julie Duszlak, David Bates, Vincent Guzman, Josue Falcon; Information Technology, Alex Romero, Henry Kupets, Frank Cortez, James C LeSuer; Administration, Andrea Hrbek, Eileen Bowes, Philomena Quinn, Megan Mele.</p>
              <p>Fred Hutchinson Cancer Research Center/Women's Health Initiative: Principal Investigator, Garnet L Anderson; Co-Investigators, Lisa Johnson, Leslie F Tinker, Aaron K Aragaki; Study Managers/Coordinators, Megan Herndon, Sue L Mann; Statisticians/Analysts, Mary Pettinger, Rebecca P Hunt; Programmers, Bill Carrick; Outcomes, Kate Szyperski, Lori Proulx-Burns, Elizabeth Burrows; Outcome Adjudicators, Marian Limacher, Judith Hsia, Ganesh Asaithambi, Muhib Khan, Nandakumar Nagaraja, Lenore C Ocava, Jana Wold, Brian Silver, Stephanie Connelly; Mailings/Processing, Gretchen Van Lom, Cris Garvida, Kathy Hightower, Patricia Spaulding; Information Technology, Wei Lin; Administration, Jenny Schoenberg, Patti Olee.</p>
              <p>Data Safety and Monitoring Board: Lawrence S Cohen (Chair), Theodore Colton, I Craig Henderson, Stephen Hulley, Alice H Lichtenstein, Eugene R Passamani, Rebecca A Silliman, Nanette Wenger, Shari E Ludlam (NIH Observer).</p>
              <p>Mars Edge: Hagen Schroeter, Michael Fare, Javier Ottawani, Catherine Kwik-Uribe.</p>
              <p>Contract Pharmacal Corp: Cassandra Arnaiz, Ann Costanza, John Greene, Paul Hennessey.</p>
              <p>Pfizer Consumer Healthcare (now GSK Consumer Healthcare): Sarma Vadlamani, Mallik Karmsetty, Paul Martini, Jan-Willem van Klinken, Alpa Shah, Lori Stern.</p>
              <p>We are deeply indebted to the 21,442 COSMOS participants for their steadfast and conscientious collaboration and to our COSMOS Research Group for their commitment and perseverance to the trial despite the challenges of the COVID-19 pandemic. We specifically acknowledge the COSMOS Research Group for their scientific [Brigham and Women's Hospital (BWH), Fred Hutchinson Cancer Research Center (FHCRC), Women's Health Initiative (WHI), Data Safety and Monitoring Board (DSMB), Mars Edge] and logistical (BWH, FHCRC, DSMB, Mars Edge, Contract Pharmacal Corp, Pfizer Consumer Healthcare (now GSK Consumer Healthcare) contributions.</p>
              <p>The authors’ responsibilities were as follows—HDS, LGJ, GF, TC, AC, GLA, and JEM: study design; HDS, GLA, and JEM: funding; HDS, PMR, LGJ, SR, GF, TC, AC, MVM, AS, JW-W, LFT, WRC, GLA, and JEM: data collection; AKA, MVM, and GLA: data analysis; HDS, PMR, AKA, GLA, and JEM: data interpretation; HDS, PMR, AKA, GLA, and JEM: writing; HDS, PMR, AKA, LGJ, SR, GF, TC, AC, SM, MVM, AS, JW-W, LFT, WRC, GLA, and JEM: critical review of manuscript; and all authors: read and approved the final manuscript. HDS and JEM reported receiving investigator-initiated grants from Mars Edge, a segment of Mars Incorporated dedicated to nutrition research and products, for infrastructure support and donation of COSMOS study pills and packaging, and Pfizer Consumer Healthcare (now part of GSK Consumer Healthcare) for donation of COSMOS study pills and packaging during the conduct of the study. HDS additionally reported receiving investigator-initiated grants from Pure Encapsulations and Pfizer Inc. and honoraria and/or travel for lectures from the Council for Responsible Nutrition, BASF, NIH, and the American Society of Nutrition during the conduct of the study. The other authors report no conflicts of interest.</p>
            </ack>
            <sec sec-type="data-availability" id="sec5">
              <title>Data Availability</title>
              <p>Data set(s) will be de-identified prior to release for sharing. We will make the data and associated documentation available to users only under a data-sharing agreement. Details on the availability of the study data to other investigators will be on our study website at <ext-link xlink:href="https://cosmostrial.org/" ext-link-type="uri">https://cosmostrial.org/</ext-link>.</p>
            </sec>
            <notes id="nt1">
              <title>Notes</title>
              <p>The COcoa Supplement and Multivitamin Outcomes Study (COSMOS) is supported by an investigator-initiated grant from Mars Edge, a segment of Mars dedicated to nutrition research and products, which included infrastructure support and the donation of study pills and packaging. Pfizer Consumer Healthcare (now part of GSK Consumer Healthcare) provided support through the partial provision of study pills and packaging. COSMOS is also supported, in part, by grants AG050657, AG071611, EY025623, and HL157665 from the National Institutes of Health, Bethesda, MD. The Women's Health Initiative (WHI) is funded by the National Heart, Lung, and Blood Institute, NIH, US Department of Health and Human Services through contracts 75N92021D00001, 75N92021D00002, 75N92021D00003, 75N92021D00004, and 75N92021D00005. Neither Mars Edge nor Pfizer (GSK) Consumer Healthcare provided input regarding the design of the study, data analyses, interpretation of results, or manuscript development nor did they review, comment, or approve the manuscript.</p>
              <p>Supplementary Methods, Supplementary Results, Supplementary Figures 1–9, and Supplementary Tables 1 and 2 are available from the “Supplementary data” link in the online posting of the article and from the same link in the online table of contents at <ext-link xlink:href="https://academic.oup.com/ajcn/" ext-link-type="uri">https://academic.oup.com/ajcn/</ext-link>.</p>
              <p>COSMOS was approved and overseen by the Institutional Review Board of Brigham and Women's Hospital/Mass General Brigham. The COSMOS website is <ext-link xlink:href="http://www.cosmostrial.org" ext-link-type="uri">www.cosmostrial.org</ext-link>.</p>
              <p>HDS and PMR contributed equally as co-first authors.</p>
              <p>Abbreviations used: BWH, Brigham and Women's Hospital; CABG, coronary artery bypass graft; COSMOS, COcoa Supplement and Multivitamin Outcomes Study; CVD, cardiovascular disease; MI, myocardial infarction; MVM, multivitamin-multimineral; PCI, percutaneous coronary intervention; PHS, Physicians’ Health Study; USPSTF, US Preventive Services Task Force; WHI, Women's Health Initiative; 25(OH)D, 25-hydroxyvitamin D.</p>
            </notes>
            <ref-list id="ref1">
              <title>References</title>
              <ref id="bib1">
                <label>1.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yetley</surname><given-names>EA</given-names></string-name></person-group>. <article-title>Multivitamin and multimineral dietary supplements: definitions, characterization, bioavailability, and drug interactions</article-title>. <source>Am J Clin Nutr</source>. <year>2007</year>;<volume>85</volume>(<issue>1</issue>):<fpage>269S</fpage>–<lpage>76S</lpage>.<pub-id pub-id-type="pmid">17209208</pub-id></mixed-citation>
              </ref>
              <ref id="bib2">
                <label>2.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kantor</surname><given-names>ED</given-names></string-name>, <string-name><surname>Rehm</surname><given-names>CD</given-names></string-name>, <string-name><surname>Du</surname><given-names>M</given-names></string-name>, <string-name><surname>White</surname><given-names>E</given-names></string-name>, <string-name><surname>Giovannucci</surname><given-names>EL</given-names></string-name></person-group>. <article-title>Trends in dietary supplement use among US adults from 1999–2012</article-title>. <source>JAMA</source>. <year>2016</year>;<volume>316</volume>(<issue>14</issue>):<fpage>1464</fpage>.<pub-id pub-id-type="pmid">27727382</pub-id></mixed-citation>
              </ref>
              <ref id="bib3">
                <label>3.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bailey</surname><given-names>RL</given-names></string-name>, <string-name><surname>Gahche</surname><given-names>JJ</given-names></string-name>, <string-name><surname>Lentino</surname><given-names>CV</given-names></string-name>, <string-name><surname>Dwyer</surname><given-names>JT</given-names></string-name>, <string-name><surname>Engel</surname><given-names>JS</given-names></string-name>, <string-name><surname>Thomas</surname><given-names>PR</given-names></string-name>, <string-name><surname>Betz</surname><given-names>JM</given-names></string-name>, <string-name><surname>Sempos</surname><given-names>CT</given-names></string-name>, <string-name><surname>Picciano</surname><given-names>MF</given-names></string-name></person-group>. <article-title>Dietary supplement use in the United States, 2003–2006</article-title>. <source>J Nutr</source>. <year>2011</year>;<volume>141</volume>(<issue>2</issue>):<fpage>261</fpage>–<lpage>6</lpage>.<pub-id pub-id-type="pmid">21178089</pub-id></mixed-citation>
              </ref>
              <ref id="bib4">
                <label>4.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gahche</surname><given-names>J</given-names></string-name>, <string-name><surname>Bailey</surname><given-names>R</given-names></string-name>, <string-name><surname>Burt</surname><given-names>V</given-names></string-name>, <string-name><surname>Hughes</surname><given-names>J</given-names></string-name>, <string-name><surname>Yetley</surname><given-names>E</given-names></string-name>, <string-name><surname>Dwyer</surname><given-names>J</given-names></string-name>, <string-name><surname>Picciano</surname><given-names>MF</given-names></string-name>, <string-name><surname>McDowell</surname><given-names>M</given-names></string-name>, <string-name><surname>Sempos</surname><given-names>C</given-names></string-name></person-group>. <article-title>Dietary supplement use among U.S. adults has increased since NHANES III (1988–1994)</article-title>. <source>NCHS Data Brief</source>. <year>2011</year>;<issue>61</issue>:<fpage>1</fpage>–<lpage>8</lpage>.</mixed-citation>
              </ref>
              <ref id="bib5">
                <label>5.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Rautiainen</surname><given-names>S</given-names></string-name>, <string-name><surname>Manson</surname><given-names>JE</given-names></string-name>, <string-name><surname>Lichtenstein</surname><given-names>AH</given-names></string-name>, <string-name><surname>Sesso</surname><given-names>HD</given-names></string-name></person-group>. <article-title>Dietary supplements and disease prevention—a global overview</article-title>. <source>Nat Rev Endocrinol</source>. <year>2016</year>;<volume>12</volume>(<issue>7</issue>):<fpage>407</fpage>–<lpage>20</lpage>.<pub-id pub-id-type="pmid">27150288</pub-id></mixed-citation>
              </ref>
              <ref id="bib6">
                <label>6.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kantor</surname><given-names>ED</given-names></string-name>, <string-name><surname>Rehm</surname><given-names>CD</given-names></string-name>, <string-name><surname>Du</surname><given-names>M</given-names></string-name>, <string-name><surname>White</surname><given-names>E</given-names></string-name>, <string-name><surname>Giovannucci</surname><given-names>EL</given-names></string-name></person-group>. <article-title>Trends in dietary supplement use among US adults from 1999–2012</article-title>. <source>JAMA</source>. <year>2016</year>;<volume>316</volume>(<issue>14</issue>):<fpage>1464</fpage>–<lpage>74</lpage>.<pub-id pub-id-type="pmid">27727382</pub-id></mixed-citation>
              </ref>
              <ref id="bib7">
                <label>7.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Inoue-Choi</surname><given-names>M</given-names></string-name>, <string-name><surname>Greenlee</surname><given-names>H</given-names></string-name>, <string-name><surname>Oppeneer</surname><given-names>SJ</given-names></string-name>, <string-name><surname>Robien</surname><given-names>K</given-names></string-name></person-group>. <article-title>The association between postdiagnosis dietary supplement use and total mortality differs by diet quality among older female cancer survivors</article-title>. <source>Cancer Epidemiol Biomarkers Prev</source>. <year>2014</year>;<volume>23</volume>(<issue>5</issue>):<fpage>865</fpage>–<lpage>75</lpage>.<pub-id pub-id-type="pmid">24621441</pub-id></mixed-citation>
              </ref>
              <ref id="bib8">
                <label>8.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gahche</surname><given-names>JJ</given-names></string-name>, <string-name><surname>Bailey</surname><given-names>RL</given-names></string-name>, <string-name><surname>Potischman</surname><given-names>N</given-names></string-name>, <string-name><surname>Dwyer</surname><given-names>JT</given-names></string-name></person-group>. <article-title>Dietary supplement use was very high among older adults in the United States in 2011–2014</article-title>. <source>J Nutr</source>. <year>2017</year>;<volume>147</volume>(<issue>10</issue>):<fpage>1968</fpage>–<lpage>76</lpage>.<pub-id pub-id-type="pmid">28855421</pub-id></mixed-citation>
              </ref>
              <ref id="bib9">
                <label>9.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Giovannucci</surname><given-names>E</given-names></string-name>, <string-name><surname>Chan</surname><given-names>AT</given-names></string-name></person-group>. <article-title>Role of vitamin and mineral supplementation and aspirin use in cancer survivors</article-title>. <source>J Clin Oncol</source>. <year>2010</year>;<volume>28</volume>(<issue>26</issue>):<fpage>4081</fpage>–<lpage>5</lpage>.<pub-id pub-id-type="pmid">20697066</pub-id></mixed-citation>
              </ref>
              <ref id="bib10">
                <label>10.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Velicer</surname><given-names>CM</given-names></string-name>, <string-name><surname>Ulrich</surname><given-names>CM</given-names></string-name></person-group>. <article-title>Vitamin and mineral supplement use among US adults after cancer diagnosis: a systematic review</article-title>. <source>J Clin Oncol</source>. <year>2008</year>;<volume>26</volume>(<issue>4</issue>):<fpage>665</fpage>–<lpage>73</lpage>.<pub-id pub-id-type="pmid">18235127</pub-id></mixed-citation>
              </ref>
              <ref id="bib11">
                <label>11.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Du</surname><given-names>M</given-names></string-name>, <string-name><surname>Luo</surname><given-names>H</given-names></string-name>, <string-name><surname>Blumberg</surname><given-names>JB</given-names></string-name>, <string-name><surname>Rogers</surname><given-names>G</given-names></string-name>, <string-name><surname>Chen</surname><given-names>F</given-names></string-name>, <string-name><surname>Ruan</surname><given-names>M</given-names></string-name>, <string-name><surname>Shan</surname><given-names>Z</given-names></string-name>, <string-name><surname>Biever</surname><given-names>E</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>FF</given-names></string-name></person-group>. <article-title>Dietary supplement use among adult cancer survivors in the United States</article-title>. <source>J Nutr</source>. <year>2020</year>;<volume>150</volume>(<issue>6</issue>):<fpage>1499</fpage>–<lpage>508</lpage>.<pub-id pub-id-type="pmid">32101612</pub-id></mixed-citation>
              </ref>
              <ref id="bib12">
                <label>12.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bailey</surname><given-names>RL</given-names></string-name>, <string-name><surname>Gahche</surname><given-names>JJ</given-names></string-name>, <string-name><surname>Miller</surname><given-names>PE</given-names></string-name>, <string-name><surname>Thomas</surname><given-names>PR</given-names></string-name>, <string-name><surname>Dwyer</surname><given-names>JT</given-names></string-name></person-group>. <article-title>Why US adults use dietary supplements</article-title>. <source>JAMA Intern Med</source>. <year>2013</year>;<volume>173</volume>(<issue>5</issue>):<fpage>355</fpage>–<lpage>61</lpage>.<pub-id pub-id-type="pmid">23381623</pub-id></mixed-citation>
              </ref>
              <ref id="bib13">
                <label>13.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Blendon</surname><given-names>RJ</given-names></string-name>, <string-name><surname>DesRoches</surname><given-names>CM</given-names></string-name>, <string-name><surname>Benson</surname><given-names>JM</given-names></string-name>, <string-name><surname>Brodie</surname><given-names>M</given-names></string-name>, <string-name><surname>Altman</surname><given-names>DE</given-names></string-name></person-group>. <article-title>Americans' views on the use and regulation of dietary supplements</article-title>. <source>Arch Intern Med</source>. <year>2001</year>;<volume>161</volume>(<issue>6</issue>):<fpage>805</fpage>–<lpage>10</lpage>.<pub-id pub-id-type="pmid">11268222</pub-id></mixed-citation>
              </ref>
              <ref id="bib14">
                <label>14.</label>
                <mixed-citation publication-type="book"><person-group person-group-type="author"><string-name><surname>Ervin</surname><given-names>RB</given-names></string-name>, <string-name><surname>Wright</surname><given-names>JD</given-names></string-name>, <string-name><surname>Kennedy-Stephenson</surname><given-names>J</given-names></string-name></person-group>. <source>Use of dietary supplements in the United States, 1988–94</source>. <publisher-loc>Washington (DC)</publisher-loc>: <publisher-name>National Center for Health Statistics</publisher-name>; <year>1999</year>.</mixed-citation>
              </ref>
              <ref id="bib15">
                <label>15.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Li</surname><given-names>K</given-names></string-name>, <string-name><surname>Kaaks</surname><given-names>R</given-names></string-name>, <string-name><surname>Linseisen</surname><given-names>J</given-names></string-name>, <string-name><surname>Rohrmann</surname><given-names>S</given-names></string-name></person-group>. <article-title>Vitamin/mineral supplementation and cancer, cardiovascular, and all-cause mortality in a German prospective cohort (EPIC-Heidelberg)</article-title>. <source>Eur J Nutr</source>. <year>2012</year>;<volume>51</volume>(<issue>4</issue>):<fpage>407</fpage>–<lpage>13</lpage>.<pub-id pub-id-type="pmid">21779961</pub-id></mixed-citation>
              </ref>
              <ref id="bib16">
                <label>16.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Park</surname><given-names>SY</given-names></string-name>, <string-name><surname>Murphy</surname><given-names>SP</given-names></string-name>, <string-name><surname>Wilkens</surname><given-names>LR</given-names></string-name>, <string-name><surname>Henderson</surname><given-names>BE</given-names></string-name>, <string-name><surname>Kolonel</surname><given-names>LN</given-names></string-name></person-group>. <article-title>Multivitamin use and the risk of mortality and cancer incidence: the Multiethnic Cohort Study</article-title>. <source>Am J Epidemiol</source>. <year>2011</year>;<volume>173</volume>(<issue>8</issue>):<fpage>906</fpage>–<lpage>14</lpage>.<pub-id pub-id-type="pmid">21343248</pub-id></mixed-citation>
              </ref>
              <ref id="bib17">
                <label>17.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Larsson</surname><given-names>SC</given-names></string-name>, <string-name><surname>Akesson</surname><given-names>A</given-names></string-name>, <string-name><surname>Bergkvist</surname><given-names>L</given-names></string-name>, <string-name><surname>Wolk</surname><given-names>A</given-names></string-name></person-group>. <article-title>Multivitamin use and breast cancer incidence in a prospective cohort of Swedish women</article-title>. <source>Am J Clin Nutr</source>. <year>2010</year>;<volume>91</volume>(<issue>5</issue>):<fpage>1268</fpage>–<lpage>72</lpage>.<pub-id pub-id-type="pmid">20335555</pub-id></mixed-citation>
              </ref>
              <ref id="bib18">
                <label>18.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Neuhouser</surname><given-names>ML</given-names></string-name>, <string-name><surname>Wassertheil-Smoller</surname><given-names>S</given-names></string-name>, <string-name><surname>Thomson</surname><given-names>C</given-names></string-name>, <string-name><surname>Aragaki</surname><given-names>A</given-names></string-name>, <string-name><surname>Anderson</surname><given-names>GL</given-names></string-name>, <string-name><surname>Manson</surname><given-names>JE</given-names></string-name>, <string-name><surname>Patterson</surname><given-names>RE</given-names></string-name>, <string-name><surname>Rohan</surname><given-names>TE</given-names></string-name>, <string-name><surname>van Horn</surname><given-names>L</given-names></string-name>, <string-name><surname>Shikany</surname><given-names>JM</given-names></string-name><etal>et al.</etal></person-group><article-title>Multivitamin use and risk of cancer and cardiovascular disease in the Women's Health Initiative cohorts</article-title>. <source>Arch Intern Med</source>. <year>2009</year>;<volume>169</volume>(<issue>3</issue>):<fpage>294</fpage>–<lpage>304</lpage>.<pub-id pub-id-type="pmid">19204221</pub-id></mixed-citation>
              </ref>
              <ref id="bib19">
                <label>19.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Stevens</surname><given-names>VL</given-names></string-name>, <string-name><surname>McCullough</surname><given-names>ML</given-names></string-name>, <string-name><surname>Diver</surname><given-names>WR</given-names></string-name>, <string-name><surname>Rodriguez</surname><given-names>C</given-names></string-name>, <string-name><surname>Jacobs</surname><given-names>EJ</given-names></string-name>, <string-name><surname>Thun</surname><given-names>MJ</given-names></string-name>, <string-name><surname>Calle</surname><given-names>EE</given-names></string-name></person-group>. <article-title>Use of multivitamins and prostate cancer mortality in a large cohort of US men</article-title>. <source>Cancer Causes Control</source>. <year>2005</year>;<volume>16</volume>(<issue>6</issue>):<fpage>643</fpage>–<lpage>50</lpage>.<pub-id pub-id-type="pmid">16049802</pub-id></mixed-citation>
              </ref>
              <ref id="bib20">
                <label>20.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jacobs</surname><given-names>EJ</given-names></string-name>, <string-name><surname>Connell</surname><given-names>CJ</given-names></string-name>, <string-name><surname>Patel</surname><given-names>AV</given-names></string-name>, <string-name><surname>Chao</surname><given-names>A</given-names></string-name>, <string-name><surname>Rodriguez</surname><given-names>C</given-names></string-name>, <string-name><surname>Seymour</surname><given-names>J</given-names></string-name>, <string-name><surname>McCullough</surname><given-names>ML</given-names></string-name>, <string-name><surname>Calle</surname><given-names>EE</given-names></string-name>, <string-name><surname>Thun</surname><given-names>MJ</given-names></string-name></person-group>. <article-title>Multivitamin use and colon cancer mortality in the Cancer Prevention Study II cohort (United States)</article-title>. <source>Cancer Causes Control</source>. <year>2001</year>;<volume>12</volume>(<issue>10</issue>):<fpage>927</fpage>–<lpage>34</lpage>.<pub-id pub-id-type="pmid">11808712</pub-id></mixed-citation>
              </ref>
              <ref id="bib21">
                <label>21.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Giovannucci</surname><given-names>E</given-names></string-name>, <string-name><surname>Stampfer</surname><given-names>MJ</given-names></string-name>, <string-name><surname>Colditz</surname><given-names>GA</given-names></string-name>, <string-name><surname>Hunter</surname><given-names>DJ</given-names></string-name>, <string-name><surname>Fuchs</surname><given-names>C</given-names></string-name>, <string-name><surname>Rosner</surname><given-names>BA</given-names></string-name>, <string-name><surname>Speizer</surname><given-names>FE</given-names></string-name>, <string-name><surname>Willett</surname><given-names>WC</given-names></string-name></person-group>. <article-title>Multivitamin use, folate, and colon cancer in women in the Nurses' Health Study</article-title>. <source>Ann Intern Med</source>. <year>1998</year>;<volume>129</volume>(<issue>7</issue>):<fpage>517</fpage>–<lpage>24</lpage>.<pub-id pub-id-type="pmid">9758570</pub-id></mixed-citation>
              </ref>
              <ref id="bib22">
                <label>22.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Asgari</surname><given-names>MM</given-names></string-name>, <string-name><surname>Chren</surname><given-names>MM</given-names></string-name>, <string-name><surname>Warton</surname><given-names>EM</given-names></string-name>, <string-name><surname>Friedman</surname><given-names>GD</given-names></string-name>, <string-name><surname>White</surname><given-names>E</given-names></string-name></person-group>. <article-title>Supplement use and risk of cutaneous squamous cell carcinoma</article-title>. <source>J Am Acad Dermatol</source>. <year>2011</year>;<volume>65</volume>(<issue>6</issue>):<fpage>1145</fpage>–<lpage>51</lpage>.<pub-id pub-id-type="pmid">21664718</pub-id></mixed-citation>
              </ref>
              <ref id="bib23">
                <label>23.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kwan</surname><given-names>ML</given-names></string-name>, <string-name><surname>Greenlee</surname><given-names>H</given-names></string-name>, <string-name><surname>Lee</surname><given-names>VS</given-names></string-name>, <string-name><surname>Castillo</surname><given-names>A</given-names></string-name>, <string-name><surname>Gunderson</surname><given-names>EP</given-names></string-name>, <string-name><surname>Habel</surname><given-names>LA</given-names></string-name>, <string-name><surname>Kushi</surname><given-names>LH</given-names></string-name>, <string-name><surname>Sweeney</surname><given-names>C</given-names></string-name>, <string-name><surname>Tam</surname><given-names>EK</given-names></string-name>, <string-name><surname>Caan</surname><given-names>BJ</given-names></string-name></person-group>. <article-title>Multivitamin use and breast cancer outcomes in women with early-stage breast cancer: the Life After Cancer Epidemiology Study</article-title>. <source>Breast Cancer Res Treat</source>. <year>2011</year>;<volume>130</volume>(<issue>1</issue>):<fpage>195</fpage>–<lpage>205</lpage>.<pub-id pub-id-type="pmid">21559824</pub-id></mixed-citation>
              </ref>
              <ref id="bib24">
                <label>24.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname><given-names>Y</given-names></string-name>, <string-name><surname>Coogan</surname><given-names>P</given-names></string-name>, <string-name><surname>Palmer</surname><given-names>JR</given-names></string-name>, <string-name><surname>Strom</surname><given-names>BL</given-names></string-name>, <string-name><surname>Rosenberg</surname><given-names>L</given-names></string-name></person-group>. <article-title>Vitamin and mineral use and risk of prostate cancer: the case-control surveillance study</article-title>. <source>Cancer Causes Control</source>. <year>2009</year>;<volume>20</volume>(<issue>5</issue>):<fpage>691</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="pmid">19093214</pub-id></mixed-citation>
              </ref>
              <ref id="bib25">
                <label>25.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bailey</surname><given-names>RL</given-names></string-name>, <string-name><surname>Fakhouri</surname><given-names>TH</given-names></string-name>, <string-name><surname>Park</surname><given-names>Y</given-names></string-name>, <string-name><surname>Dwyer</surname><given-names>JT</given-names></string-name>, <string-name><surname>Thomas</surname><given-names>PR</given-names></string-name>, <string-name><surname>Gahche</surname><given-names>JJ</given-names></string-name>, <string-name><surname>Miller</surname><given-names>PE</given-names></string-name>, <string-name><surname>Dodd</surname><given-names>KW</given-names></string-name>, <string-name><surname>Sempos</surname><given-names>CT</given-names></string-name>, <string-name><surname>Murray</surname><given-names>DM</given-names></string-name></person-group>. <article-title>Multivitamin-mineral use is associated with reduced risk of cardiovascular disease mortality among women in the United States</article-title>. <source>J Nutr</source>. <year>2015</year>;<volume>145</volume>(<issue>3</issue>):<fpage>572</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="pmid">25733474</pub-id></mixed-citation>
              </ref>
              <ref id="bib26">
                <label>26.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Pocobelli</surname><given-names>G</given-names></string-name>, <string-name><surname>Peters</surname><given-names>U</given-names></string-name>, <string-name><surname>Kristal</surname><given-names>AR</given-names></string-name>, <string-name><surname>White</surname><given-names>E</given-names></string-name></person-group>. <article-title>Use of supplements of multivitamins, vitamin C, and vitamin E in relation to mortality</article-title>. <source>Am J Epidemiol</source>. <year>2009</year>;<volume>170</volume>(<issue>4</issue>):<fpage>472</fpage>–<lpage>83</lpage>.<pub-id pub-id-type="pmid">19596711</pub-id></mixed-citation>
              </ref>
              <ref id="bib27">
                <label>27.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Rautiainen</surname><given-names>S</given-names></string-name>, <string-name><surname>Lee</surname><given-names>IM</given-names></string-name>, <string-name><surname>Rist</surname><given-names>PM</given-names></string-name>, <string-name><surname>Gaziano</surname><given-names>JM</given-names></string-name>, <string-name><surname>Manson</surname><given-names>JE</given-names></string-name>, <string-name><surname>Buring</surname><given-names>JE</given-names></string-name>, <string-name><surname>Sesso</surname><given-names>HD</given-names></string-name></person-group>. <article-title>Multivitamin use and cardiovascular disease in a prospective study of women</article-title>. <source>Am J Clin Nutr</source>. <year>2015</year>;<volume>101</volume>(<issue>1</issue>):<fpage>144</fpage>–<lpage>52</lpage>.<pub-id pub-id-type="pmid">25527758</pub-id></mixed-citation>
              </ref>
              <ref id="bib28">
                <label>28.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Rautiainen</surname><given-names>S</given-names></string-name>, <string-name><surname>Rist</surname><given-names>PM</given-names></string-name>, <string-name><surname>Glynn</surname><given-names>RJ</given-names></string-name>, <string-name><surname>Buring</surname><given-names>JE</given-names></string-name>, <string-name><surname>Gaziano</surname><given-names>JM</given-names></string-name>, <string-name><surname>Sesso</surname><given-names>HD</given-names></string-name></person-group>. <article-title>Multivitamin use and the risk of cardiovascular disease in men</article-title>. <source>J Nutr</source>. <year>2016</year>;<volume>146</volume>(<issue>6</issue>):<fpage>1235</fpage>–<lpage>40</lpage>.<pub-id pub-id-type="pmid">27121531</pub-id></mixed-citation>
              </ref>
              <ref id="bib29">
                <label>29.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Xu</surname><given-names>X</given-names></string-name>, <string-name><surname>Shi</surname><given-names>Z</given-names></string-name>, <string-name><surname>Liu</surname><given-names>G</given-names></string-name>, <string-name><surname>Chang</surname><given-names>D</given-names></string-name>, <string-name><surname>Inglis</surname><given-names>SC</given-names></string-name>, <string-name><surname>Hall</surname><given-names>JJ</given-names></string-name>, <string-name><surname>Schutte</surname><given-names>AE</given-names></string-name>, <string-name><surname>Byles</surname><given-names>JE</given-names></string-name>, <string-name><surname>Parker</surname><given-names>D</given-names></string-name></person-group>. <article-title>The joint effects of diet and dietary supplements in relation to obesity and cardiovascular disease over a 10-year follow-up: a longitudinal study of 69,990 participants in Australia</article-title>. <source>Nutrients</source>. <year>2021</year>;<volume>13</volume>(<issue>3</issue>):<fpage>944</fpage>.<pub-id pub-id-type="pmid">33804132</pub-id></mixed-citation>
              </ref>
              <ref id="bib30">
                <label>30.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gaziano</surname><given-names>JM</given-names></string-name>, <string-name><surname>Sesso</surname><given-names>HD</given-names></string-name>, <string-name><surname>Christen</surname><given-names>WG</given-names></string-name>, <string-name><surname>Bubes</surname><given-names>V</given-names></string-name>, <string-name><surname>Smith</surname><given-names>JP</given-names></string-name>, <string-name><surname>MacFadyen</surname><given-names>J</given-names></string-name>, <string-name><surname>Schvartz</surname><given-names>M</given-names></string-name>, <string-name><surname>Manson</surname><given-names>JE</given-names></string-name>, <string-name><surname>Glynn</surname><given-names>RJ</given-names></string-name>, <string-name><surname>Buring</surname><given-names>JE</given-names></string-name></person-group>. <article-title>Multivitamins in the prevention of cancer in men: the Physicians' Health Study II randomized controlled trial</article-title>. <source>JAMA</source>. <year>2012</year>;<volume>308</volume>(<issue>18</issue>):<fpage>1871</fpage>–<lpage>80</lpage>.<pub-id pub-id-type="pmid">23162860</pub-id></mixed-citation>
              </ref>
              <ref id="bib31">
                <label>31.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sesso</surname><given-names>HD</given-names></string-name>, <string-name><surname>Christen</surname><given-names>WG</given-names></string-name>, <string-name><surname>Bubes</surname><given-names>V</given-names></string-name>, <string-name><surname>Smith</surname><given-names>JP</given-names></string-name>, <string-name><surname>MacFadyen</surname><given-names>J</given-names></string-name>, <string-name><surname>Schvartz</surname><given-names>M</given-names></string-name>, <string-name><surname>Manson</surname><given-names>JE</given-names></string-name>, <string-name><surname>Glynn</surname><given-names>RJ</given-names></string-name>, <string-name><surname>Buring</surname><given-names>JE</given-names></string-name>, <string-name><surname>Gaziano</surname><given-names>JM</given-names></string-name></person-group>. <article-title>Multivitamins in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial</article-title>. <source>JAMA</source>. <year>2012</year>;<volume>308</volume>(<issue>17</issue>):<fpage>1751</fpage>–<lpage>60</lpage>.<pub-id pub-id-type="pmid">23117775</pub-id></mixed-citation>
              </ref>
              <ref id="bib67_1647528923391">
                <label>32.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Rist</surname><given-names>PM</given-names></string-name>, <string-name><surname>Sesso</surname><given-names>HD</given-names></string-name>, <string-name><surname>Johnson</surname><given-names>LG</given-names></string-name>, <string-name><surname>Aragaki</surname><given-names>AK</given-names></string-name>, <string-name><surname>Wang</surname><given-names>L</given-names></string-name>, <string-name><surname>Rautiainen</surname><given-names>S</given-names></string-name>, <string-name><surname>Hazra</surname><given-names>A</given-names></string-name>, <string-name><surname>Tobias</surname><given-names>DK</given-names></string-name>, <string-name><surname>LeBoff</surname><given-names>MS</given-names></string-name>, <string-name><surname>Schroeter</surname><given-names>H</given-names></string-name><etal>et al.</etal></person-group><article-title>Design and baseline characteristics of participants in the COcoa Supplement and Multivitamins Outcomes Study (COSMOS)</article-title>. <source>Contemp Clin Trials</source>. <year>2022</year>;<volume>116</volume>:<fpage>106728</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cct.2022.106728</pub-id>.<pub-id pub-id-type="pmid">35288332</pub-id></mixed-citation>
              </ref>
              <ref id="bib32">
                <label>33.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cauley</surname><given-names>JA</given-names></string-name>, <string-name><surname>Crandall</surname><given-names>C</given-names></string-name></person-group>. <article-title>The Women's Health Initiative: a landmark resource for skeletal research since 1992</article-title>. <source>J Bone Miner Res</source>. <year>2020</year>;<volume>35</volume>(<issue>5</issue>):<fpage>845</fpage>–<lpage>60</lpage>.<pub-id pub-id-type="pmid">32286708</pub-id></mixed-citation>
              </ref>
              <ref id="bib33">
                <label>34.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bassuk</surname><given-names>SS</given-names></string-name>, <string-name><surname>Manson</surname><given-names>JE</given-names></string-name>, <string-name><surname>Lee</surname><given-names>IM</given-names></string-name>, <string-name><surname>Cook</surname><given-names>NR</given-names></string-name>, <string-name><surname>Christen</surname><given-names>WG</given-names></string-name>, <string-name><surname>Bubes</surname><given-names>VY</given-names></string-name>, <string-name><surname>Gordon</surname><given-names>DS</given-names></string-name>, <string-name><surname>Copeland</surname><given-names>T</given-names></string-name>, <string-name><surname>Friedenberg</surname><given-names>G</given-names></string-name>, <string-name><surname>D'Agostino</surname><given-names>DM</given-names></string-name><etal>et al.</etal></person-group><article-title>Baseline characteristics of participants in the VITamin D and Omega-3 TriaL (VITAL)</article-title>. <source>Contemp Clin Trials</source>. <year>2016</year>;<volume>47</volume>:<fpage>235</fpage>–<lpage>43</lpage>.<pub-id pub-id-type="pmid">26767629</pub-id></mixed-citation>
              </ref>
              <ref id="bib34">
                <label>35.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lang</surname><given-names>JM</given-names></string-name>, <string-name><surname>Buring</surname><given-names>JE</given-names></string-name>, <string-name><surname>Rosner</surname><given-names>B</given-names></string-name>, <string-name><surname>Cook</surname><given-names>N</given-names></string-name>, <string-name><surname>Hennekens</surname><given-names>CH</given-names></string-name></person-group>. <article-title>Estimating the effect of the run-in on the power of the Physicians' Health Study</article-title>. <source>Stat Med</source>. <year>1991</year>;<volume>10</volume>(<issue>10</issue>):<fpage>1585</fpage>–<lpage>93</lpage>.<pub-id pub-id-type="pmid">1947514</pub-id></mixed-citation>
              </ref>
              <ref id="bib35">
                <label>36.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Curb</surname><given-names>JD</given-names></string-name>, <string-name><surname>McTiernan</surname><given-names>A</given-names></string-name>, <string-name><surname>Heckbert</surname><given-names>SR</given-names></string-name>, <string-name><surname>Kooperberg</surname><given-names>C</given-names></string-name>, <string-name><surname>Stanford</surname><given-names>J</given-names></string-name>, <string-name><surname>Nevitt</surname><given-names>M</given-names></string-name>, <string-name><surname>Johnson</surname><given-names>KC</given-names></string-name>, <string-name><surname>Proulx-Burns</surname><given-names>L</given-names></string-name>, <string-name><surname>Pastore</surname><given-names>L</given-names></string-name>, <string-name><surname>Criqui</surname><given-names>M</given-names></string-name><etal>et al.</etal></person-group><article-title>Outcomes ascertainment and adjudication methods in the Women's Health Initiative</article-title>. <source>Ann Epidemiol</source>. <year>2003</year>;<volume>13</volume>(<issue>9 Suppl</issue>):<fpage>S122</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="pmid">14575944</pub-id></mixed-citation>
              </ref>
              <ref id="bib36">
                <label>37.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Adams</surname><given-names>HP</given-names><suffix>Jr</suffix></string-name>, <string-name><surname>Bendixen</surname><given-names>BH</given-names></string-name>, <string-name><surname>Kappelle</surname><given-names>LJ</given-names></string-name>, <string-name><surname>Biller</surname><given-names>J</given-names></string-name>, <string-name><surname>Love</surname><given-names>BB</given-names></string-name>, <string-name><surname>Gordon</surname><given-names>DL</given-names></string-name>, <string-name><surname>Marsh</surname><given-names>EE</given-names><suffix>3rd</suffix></string-name></person-group>. <article-title>Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST: Trial of Org 10172 in Acute Stroke Treatment</article-title>. <source>Stroke</source>. <year>1993</year>;<volume>24</volume>(<issue>1</issue>):<fpage>35</fpage>–<lpage>41</lpage>.<pub-id pub-id-type="pmid">7678184</pub-id></mixed-citation>
              </ref>
              <ref id="bib37">
                <label>38.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bamford</surname><given-names>J</given-names></string-name>, <string-name><surname>Sandercock</surname><given-names>P</given-names></string-name>, <string-name><surname>Dennis</surname><given-names>M</given-names></string-name>, <string-name><surname>Burn</surname><given-names>J</given-names></string-name>, <string-name><surname>Warlow</surname><given-names>C</given-names></string-name></person-group>. <article-title>Classification and natural history of clinically identifiable subtypes of cerebral infarction</article-title>. <source>Lancet North Am Ed</source>. <year>1991</year>;<volume>337</volume>(<issue>8756</issue>):<fpage>1521</fpage>–<lpage>6</lpage>.</mixed-citation>
              </ref>
              <ref id="bib38">
                <label>39.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cox</surname><given-names>DR</given-names></string-name></person-group>. <article-title>Regression models and life-tables</article-title>. <source>J Royal Statist Soc B</source>. <year>1972</year>;<volume>34</volume>:<fpage>187</fpage>–<lpage>220</lpage>.</mixed-citation>
              </ref>
              <ref id="bib39">
                <label>40.</label>
                <mixed-citation publication-type="book"><person-group person-group-type="author"><string-name><surname>Therneau</surname><given-names>TM</given-names></string-name>, <string-name><surname>Grambsch</surname><given-names>PM</given-names></string-name></person-group>. <source>Modeling survival data: extending the Cox model</source>. <publisher-loc>New York</publisher-loc>: <publisher-name>Springer</publisher-name>; <year>2000</year>.</mixed-citation>
              </ref>
              <ref id="bib40">
                <label>41.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Fortmann</surname><given-names>SP</given-names></string-name>, <string-name><surname>Burda</surname><given-names>BU</given-names></string-name>, <string-name><surname>Senger</surname><given-names>CA</given-names></string-name>, <string-name><surname>Lin</surname><given-names>JS</given-names></string-name>, <string-name><surname>Whitlock</surname><given-names>EP</given-names></string-name></person-group>. <article-title>Vitamin and mineral supplements in the primary prevention of cardiovascular disease and cancer: an updated systematic evidence review for the U.S. Preventive Services Task Force</article-title>. <source>Ann Intern Med</source>. <year>2013</year>;<volume>159</volume>(<issue>12</issue>):<fpage>824</fpage>–<lpage>34</lpage>.<pub-id pub-id-type="pmid">24217421</pub-id></mixed-citation>
              </ref>
              <ref id="bib41">
                <label>42.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Moyer</surname><given-names>VA</given-names></string-name>, <string-name><surname>Force</surname><given-names>U</given-names></string-name></person-group>. <article-title>Vitamin, mineral, and multivitamin supplements for the primary prevention of cardiovascular disease and cancer: U.S. Preventive Services Task Force recommendation statement</article-title>. <source>Ann Intern Med</source>. <year>2014</year>;<volume>160</volume>(<issue>8</issue>):<fpage>558</fpage>–<lpage>64</lpage>.<pub-id pub-id-type="pmid">24566474</pub-id></mixed-citation>
              </ref>
              <ref id="bib42">
                <label>43.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>O'Connor</surname><given-names>EA</given-names></string-name>, <string-name><surname>Evans</surname><given-names>CV</given-names></string-name>, <string-name><surname>Ivlev</surname><given-names>I</given-names></string-name>, <string-name><surname>Rushkin</surname><given-names>MC</given-names></string-name>, <string-name><surname>Thomas</surname><given-names>RG</given-names></string-name>, <string-name><surname>Martin</surname><given-names>A</given-names></string-name>, <string-name><surname>Lin</surname><given-names>JS</given-names></string-name></person-group>. <article-title>Vitamin and mineral supplements for the primary prevention of cardiovascular disease and cancer: a systematic evidence review for the U.S. Preventive Services Task Force</article-title>. <year>2021</year>.</mixed-citation>
              </ref>
              <ref id="bib43">
                <label>44.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cowan</surname><given-names>A</given-names></string-name>, <string-name><surname>Jun</surname><given-names>S</given-names></string-name>, <string-name><surname>Gahche</surname><given-names>J</given-names></string-name>, <string-name><surname>Tooze</surname><given-names>J</given-names></string-name>, <string-name><surname>Dwyer</surname><given-names>J</given-names></string-name>, <string-name><surname>Eicher-Miller</surname><given-names>H</given-names></string-name>, <string-name><surname>Bhadra</surname><given-names>A</given-names></string-name>, <string-name><surname>Guenther</surname><given-names>P</given-names></string-name>, <string-name><surname>Potischman</surname><given-names>N</given-names></string-name>, <string-name><surname>Dodd</surname><given-names>K</given-names></string-name><etal>et al.</etal></person-group><article-title>Dietary supplement use differs by socioeconomic and health-related characteristics among U.S. adults, NHANES 2011–2014</article-title>. <source>Nutrients</source>. <year>2018</year>;<volume>10</volume>(<issue>8</issue>):<fpage>1114</fpage>.</mixed-citation>
              </ref>
              <ref id="bib44">
                <label>45.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Rautiainen</surname><given-names>S</given-names></string-name>, <string-name><surname>Wang</surname><given-names>L</given-names></string-name>, <string-name><surname>Gaziano</surname><given-names>JM</given-names></string-name>, <string-name><surname>Sesso</surname><given-names>HD</given-names></string-name></person-group>. <article-title>Who uses multivitamins? A cross-sectional study in the Physicians' Health Study</article-title>. <source>Eur J Nutr</source>. <year>2014</year>;<volume>53</volume>(<issue>4</issue>):<fpage>1065</fpage>–<lpage>72</lpage>.<pub-id pub-id-type="pmid">24170064</pub-id></mixed-citation>
              </ref>
              <ref id="bib45">
                <label>46.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bailey</surname><given-names>RL</given-names></string-name></person-group>. <article-title>Current regulatory guidelines and resources to support research of dietary supplements in the United States</article-title>. <source>Crit Rev Food Sci Nutr</source>. <year>2020</year>;<volume>60</volume>(<issue>2</issue>):<fpage>298</fpage>–<lpage>309</lpage>.<pub-id pub-id-type="pmid">30421981</pub-id></mixed-citation>
              </ref>
              <ref id="bib46">
                <label>47.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Marnett</surname><given-names>LJ</given-names></string-name></person-group>. <article-title>Peroxyl free radicals: potential mediators of tumor initiation and promotion</article-title>. <source>Carcinogenesis</source>. <year>1987</year>;<volume>8</volume>(<issue>10</issue>):<fpage>1365</fpage>–<lpage>73</lpage>.<pub-id pub-id-type="pmid">3477337</pub-id></mixed-citation>
              </ref>
              <ref id="bib47">
                <label>48.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Breimer</surname><given-names>LH</given-names></string-name></person-group>. <article-title>Molecular mechanisms of oxygen radical carcinogenesis and mutagenesis: the role of DNA base damage</article-title>. <source>Mol Carcinog</source>. <year>1990</year>;<volume>3</volume>(<issue>4</issue>):<fpage>188</fpage>–<lpage>97</lpage>.<pub-id pub-id-type="pmid">2206282</pub-id></mixed-citation>
              </ref>
              <ref id="bib48">
                <label>49.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Packer</surname><given-names>L</given-names></string-name></person-group>. <article-title>Protective role of vitamin E in biological systems</article-title>. <source>Am J Clin Nutr</source>. <year>1991</year>;<volume>53</volume>(<issue>4</issue>):<fpage>1050S</fpage>–<lpage>5S</lpage>.<pub-id pub-id-type="pmid">2012017</pub-id></mixed-citation>
              </ref>
              <ref id="bib49">
                <label>50.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Meydani</surname><given-names>SN</given-names></string-name>, <string-name><surname>Barklund</surname><given-names>MP</given-names></string-name>, <string-name><surname>Liu</surname><given-names>S</given-names></string-name>, <string-name><surname>Meydani</surname><given-names>M</given-names></string-name>, <string-name><surname>Miller</surname><given-names>RA</given-names></string-name>, <string-name><surname>Cannon</surname><given-names>JG</given-names></string-name>, <string-name><surname>Morrow</surname><given-names>FD</given-names></string-name>, <string-name><surname>Rocklin</surname><given-names>R</given-names></string-name>, <string-name><surname>Blumberg</surname><given-names>JB</given-names></string-name></person-group>. <article-title>Vitamin E supplementation enhances cell-mediated immunity in healthy elderly subjects</article-title>. <source>Am J Clin Nutr</source>. <year>1990</year>;<volume>52</volume>(<issue>3</issue>):<fpage>557</fpage>–<lpage>63</lpage>.<pub-id pub-id-type="pmid">2203257</pub-id></mixed-citation>
              </ref>
              <ref id="bib50">
                <label>51.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chen</surname><given-names>LH</given-names></string-name>, <string-name><surname>Boissonneault</surname><given-names>GA</given-names></string-name>, <string-name><surname>Glauert</surname><given-names>HP</given-names></string-name></person-group>. <article-title>Vitamin C, vitamin E and cancer (review)</article-title>. <source>Anticancer Res</source>. <year>1988</year>;<volume>8</volume>(<issue>4</issue>):<fpage>739</fpage>–<lpage>48</lpage>.<pub-id pub-id-type="pmid">3052251</pub-id></mixed-citation>
              </ref>
              <ref id="bib51">
                <label>52.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Knekt</surname><given-names>P</given-names></string-name></person-group>. <article-title>Role of vitamin E in the prophylaxis of cancer</article-title>. <source>Ann Med</source>. <year>1991</year>;<volume>23</volume>(<issue>1</issue>):<fpage>3</fpage>–<lpage>12</lpage>.<pub-id pub-id-type="pmid">2036202</pub-id></mixed-citation>
              </ref>
              <ref id="bib52">
                <label>53.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Liehr</surname><given-names>JG</given-names></string-name></person-group>. <article-title>Vitamin C reduces the incidence and severity of renal tumors induced by estradiol or diethylstilbestrol</article-title>. <source>Am J Clin Nutr</source>. <year>1991</year>;<volume>54</volume>(<issue>6</issue>):<fpage>1256S</fpage>–<lpage>60S</lpage>.<pub-id pub-id-type="pmid">1962579</pub-id></mixed-citation>
              </ref>
              <ref id="bib53">
                <label>54.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Giovannucci</surname><given-names>E</given-names></string-name>, <string-name><surname>Rimm</surname><given-names>EB</given-names></string-name>, <string-name><surname>Ascherio</surname><given-names>A</given-names></string-name>, <string-name><surname>Stampfer</surname><given-names>MJ</given-names></string-name>, <string-name><surname>Colditz</surname><given-names>GA</given-names></string-name>, <string-name><surname>Willett</surname><given-names>WC</given-names></string-name></person-group>. <article-title>Alcohol, low-methionine–low-folate diets, and risk of colon cancer in men</article-title>. <source>J Natl Cancer Inst</source>. <year>1995</year>;<volume>87</volume>(<issue>4</issue>):<fpage>265</fpage>–<lpage>73</lpage>.<pub-id pub-id-type="pmid">7707417</pub-id></mixed-citation>
              </ref>
              <ref id="bib54">
                <label>55.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Giovannucci</surname><given-names>E</given-names></string-name>, <string-name><surname>Stampfer</surname><given-names>MJ</given-names></string-name>, <string-name><surname>Colditz</surname><given-names>GA</given-names></string-name>, <string-name><surname>Rimm</surname><given-names>EB</given-names></string-name>, <string-name><surname>Trichopoulos</surname><given-names>D</given-names></string-name>, <string-name><surname>Rosner</surname><given-names>BA</given-names></string-name>, <string-name><surname>Speizer</surname><given-names>FE</given-names></string-name>, <string-name><surname>Willett</surname><given-names>WC</given-names></string-name></person-group>. <article-title>Folate, methionine, and alcohol intake and risk of colorectal adenoma</article-title>. <source>J Natl Cancer Inst</source>. <year>1993</year>;<volume>85</volume>(<issue>11</issue>):<fpage>875</fpage>–<lpage>83</lpage>.<pub-id pub-id-type="pmid">8492316</pub-id></mixed-citation>
              </ref>
              <ref id="bib55">
                <label>56.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Joshipura</surname><given-names>KJ</given-names></string-name>, <string-name><surname>Hu</surname><given-names>FB</given-names></string-name>, <string-name><surname>Manson</surname><given-names>JE</given-names></string-name>, <string-name><surname>Stampfer</surname><given-names>MJ</given-names></string-name>, <string-name><surname>Rimm</surname><given-names>EB</given-names></string-name>, <string-name><surname>Speizer</surname><given-names>FE</given-names></string-name>, <string-name><surname>Colditz</surname><given-names>G</given-names></string-name>, <string-name><surname>Ascherio</surname><given-names>A</given-names></string-name>, <string-name><surname>Rosner</surname><given-names>B</given-names></string-name>, <string-name><surname>Spiegelman</surname><given-names>D</given-names></string-name><etal>et al.</etal></person-group><article-title>The effect of fruit and vegetable intake on risk for coronary heart disease</article-title>. <source>Ann Intern Med</source>. <year>2001</year>;<volume>134</volume>(<issue>12</issue>):<fpage>1106</fpage>–<lpage>14</lpage>.<pub-id pub-id-type="pmid">11412050</pub-id></mixed-citation>
              </ref>
              <ref id="bib56">
                <label>57.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Joshipura</surname><given-names>KJ</given-names></string-name>, <string-name><surname>Ascherio</surname><given-names>A</given-names></string-name>, <string-name><surname>Manson</surname><given-names>JE</given-names></string-name>, <string-name><surname>Stampfer</surname><given-names>MJ</given-names></string-name>, <string-name><surname>Rimm</surname><given-names>EB</given-names></string-name>, <string-name><surname>Speizer</surname><given-names>FE</given-names></string-name>, <string-name><surname>Hennekens</surname><given-names>CH</given-names></string-name>, <string-name><surname>Spiegelman</surname><given-names>D</given-names></string-name>, <string-name><surname>Willett</surname><given-names>WC</given-names></string-name></person-group>. <article-title>Fruit and vegetable intake in relation to risk of ischemic stroke</article-title>. <source>JAMA</source>. <year>1999</year>;<volume>282</volume>(<issue>13</issue>):<fpage>1233</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">10517425</pub-id></mixed-citation>
              </ref>
              <ref id="bib57">
                <label>58.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Blumberg</surname><given-names>JB</given-names></string-name>, <string-name><surname>Cena</surname><given-names>H</given-names></string-name>, <string-name><surname>Barr</surname><given-names>SI</given-names></string-name>, <string-name><surname>Biesalski</surname><given-names>HK</given-names></string-name>, <string-name><surname>Dagach</surname><given-names>RU</given-names></string-name>, <string-name><surname>Delaney</surname><given-names>B</given-names></string-name>, <string-name><surname>Frei</surname><given-names>B</given-names></string-name>, <string-name><surname>Moreno González</surname><given-names>MI</given-names></string-name>, <string-name><surname>Hwalla</surname><given-names>N</given-names></string-name>, <string-name><surname>Lategan-Potgieter</surname><given-names>R</given-names></string-name><etal>et al.</etal></person-group><article-title>The use of multivitamin/multimineral supplements: a modified Delphi Consensus Panel Report</article-title>. <source>Clin Ther</source>. <year>2018</year>;<volume>40</volume>(<issue>4</issue>):<fpage>640</fpage>–<lpage>57</lpage>.<pub-id pub-id-type="pmid">29573851</pub-id></mixed-citation>
              </ref>
              <ref id="bib58">
                <label>59.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Watkins</surname><given-names>ML</given-names></string-name>, <string-name><surname>Erickson</surname><given-names>JD</given-names></string-name>, <string-name><surname>Thun</surname><given-names>MJ</given-names></string-name>, <string-name><surname>Mulinare</surname><given-names>J</given-names></string-name>, <string-name><surname>Heath</surname><given-names>CW</given-names><suffix>Jr.</suffix></string-name></person-group><article-title>Multivitamin use and mortality in a large prospective study</article-title>. <source>Am J Epidemiol</source>. <year>2000</year>;<volume>152</volume>(<issue>2</issue>):<fpage>149</fpage>–<lpage>62</lpage>.<pub-id pub-id-type="pmid">10909952</pub-id></mixed-citation>
              </ref>
              <ref id="bib59">
                <label>60.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jacobs</surname><given-names>EJ</given-names></string-name>, <string-name><surname>Connell</surname><given-names>CJ</given-names></string-name>, <string-name><surname>Chao</surname><given-names>A</given-names></string-name>, <string-name><surname>McCullough</surname><given-names>ML</given-names></string-name>, <string-name><surname>Rodriguez</surname><given-names>C</given-names></string-name>, <string-name><surname>Thun</surname><given-names>MJ</given-names></string-name>, <string-name><surname>Calle</surname><given-names>EE</given-names></string-name></person-group>. <article-title>Multivitamin use and colorectal cancer incidence in a US cohort: does timing matter?</article-title>. <source>Am J Epidemiol</source>. <year>2003</year>;<volume>158</volume>(<issue>7</issue>):<fpage>621</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="pmid">14507597</pub-id></mixed-citation>
              </ref>
              <ref id="bib60">
                <label>61.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Blot</surname><given-names>WJ</given-names></string-name>, <string-name><surname>Li</surname><given-names>JY</given-names></string-name>, <string-name><surname>Taylor</surname><given-names>PR</given-names></string-name>, <string-name><surname>Guo</surname><given-names>W</given-names></string-name>, <string-name><surname>Dawsey</surname><given-names>S</given-names></string-name>, <string-name><surname>Wang</surname><given-names>GQ</given-names></string-name>, <string-name><surname>Yang</surname><given-names>CS</given-names></string-name>, <string-name><surname>Zheng</surname><given-names>SF</given-names></string-name>, <string-name><surname>Gail</surname><given-names>M</given-names></string-name>, <string-name><surname>Li</surname><given-names>GY</given-names></string-name><etal>et al.</etal></person-group><article-title>Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population</article-title>. <source>J Natl Cancer Inst</source>. <year>1993</year>;<volume>85</volume>(<issue>18</issue>):<fpage>1483</fpage>–<lpage>91</lpage>.<pub-id pub-id-type="pmid">8360931</pub-id></mixed-citation>
              </ref>
              <ref id="bib61">
                <label>62.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Qiao</surname><given-names>YL</given-names></string-name>, <string-name><surname>Dawsey</surname><given-names>SM</given-names></string-name>, <string-name><surname>Kamangar</surname><given-names>F</given-names></string-name>, <string-name><surname>Fan</surname><given-names>JH</given-names></string-name>, <string-name><surname>Abnet</surname><given-names>CC</given-names></string-name>, <string-name><surname>Sun</surname><given-names>XD</given-names></string-name>, <string-name><surname>Johnson</surname><given-names>LL</given-names></string-name>, <string-name><surname>Gail</surname><given-names>MH</given-names></string-name>, <string-name><surname>Dong</surname><given-names>ZW</given-names></string-name>, <string-name><surname>Yu</surname><given-names>B</given-names></string-name><etal>et al.</etal></person-group><article-title>Total and cancer mortality after supplementation with vitamins and minerals: follow-up of the Linxian General Population Nutrition Intervention Trial</article-title>. <source>J Natl Cancer Inst</source>. <year>2009</year>;<volume>101</volume>(<issue>7</issue>):<fpage>507</fpage>–<lpage>18</lpage>.<pub-id pub-id-type="pmid">19318634</pub-id></mixed-citation>
              </ref>
              <ref id="bib62">
                <label>63.</label>
                <mixed-citation publication-type="journal"><article-title>MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial</article-title>. <source>Lancet North Am Ed</source>. <year>2002</year>;<volume>360</volume>(<issue>9326</issue>):<fpage>23</fpage>–<lpage>33</lpage>.</mixed-citation>
              </ref>
              <ref id="bib63">
                <label>64.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hercberg</surname><given-names>S</given-names></string-name>, <string-name><surname>Galan</surname><given-names>P</given-names></string-name>, <string-name><surname>Preziosi</surname><given-names>P</given-names></string-name>, <string-name><surname>Bertrais</surname><given-names>S</given-names></string-name>, <string-name><surname>Mennen</surname><given-names>L</given-names></string-name>, <string-name><surname>Malvy</surname><given-names>D</given-names></string-name>, <string-name><surname>Roussel</surname><given-names>AM</given-names></string-name>, <string-name><surname>Favier</surname><given-names>A</given-names></string-name>, <string-name><surname>Briancon</surname><given-names>S</given-names></string-name></person-group>. <article-title>The SU.VI.MAX study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals</article-title>. <source>Arch Intern Med</source>. <year>2004</year>;<volume>164</volume>(<issue>21</issue>):<fpage>2335</fpage>–<lpage>42</lpage>.<pub-id pub-id-type="pmid">15557412</pub-id></mixed-citation>
              </ref>
              <ref id="bib64">
                <label>65.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Morris</surname><given-names>MC</given-names></string-name>, <string-name><surname>Tangney</surname><given-names>CC</given-names></string-name></person-group>. <article-title>A potential design flaw of randomized trials of vitamin supplements</article-title>. <source>JAMA</source>. <year>2011</year>;<volume>305</volume>(<issue>13</issue>):<fpage>1348</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">21467288</pub-id></mixed-citation>
              </ref>
              <ref id="bib65">
                <label>66.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wallace</surname><given-names>TC</given-names></string-name>, <string-name><surname>Frankenfeld</surname><given-names>CL</given-names></string-name>, <string-name><surname>Frei</surname><given-names>B</given-names></string-name>, <string-name><surname>Shah</surname><given-names>AV</given-names></string-name>, <string-name><surname>Yu</surname><given-names>CR</given-names></string-name>, <string-name><surname>van Klinken</surname><given-names>BJ</given-names></string-name>, <string-name><surname>Adeleke</surname><given-names>M.</given-names></string-name></person-group><article-title>Multivitamin/multimineral supplement use is associated with increased micronutrient intakes and biomarkers and decreased prevalence of inadequacies and deficiencies in middle-aged and older adults in the United States</article-title>. <source>J Nutr Gerontol Geriatr</source>. <year>2019</year>;<volume>38</volume>(<issue>4</issue>):<fpage>307</fpage>–<lpage>28</lpage>.<pub-id pub-id-type="pmid">31502930</pub-id></mixed-citation>
              </ref>
              <ref id="bib66">
                <label>67.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Rist</surname><given-names>PM</given-names></string-name>, <string-name><surname>Sesso</surname><given-names>HD</given-names></string-name>, <string-name><surname>Manson</surname><given-names>JE</given-names></string-name></person-group>. <article-title>Innovation in the design of large-scale hybrid randomized clinical trials</article-title>. <source>Contemp Clin Trials</source>. <year>2020</year>;<volume>99</volume>:<fpage>106178</fpage>.<pub-id pub-id-type="pmid">33086158</pub-id></mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
